Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 65
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Reseña (Review)

Targeting Viral Transcription for HIV Cure Strategies

  • Izquierdo-Pujol, Jon|||0000-0002-5903-9909
  • Puertas, Maria C.|||0000-0002-6750-2318
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
  • Moron-Lopez, Sara|||0000-0003-0800-9205
Combination antiretroviral therapy (ART) suppresses viral replication to undetectable levels, reduces mortality and morbidity, and improves the quality of life of people living with HIV (PWH). However, ART cannot cure HIV infection because it is unable to eliminate latently infected cells. HIV latency may be regulated by different HIV transcription mechanisms, such as blocks to initiation, elongation, and post-transcriptional processes. Several latency-reversing (LRA) and -promoting agents (LPA) have been investigated in clinical trials aiming to eliminate or reduce the HIV reservoir. However, none of these trials has shown a conclusive impact on the HIV reservoir. Here, we review the cellular and viral factors that regulate HIV-1 transcription, the potential pharmacological targets and genetic and epigenetic editing techniques that have been or might be evaluated to disrupt HIV-1 latency, the role of miRNA in post-transcriptional regulation of HIV-1, and the differences between the mechanisms regulating HIV-1 and HIV-2 expression.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides

  • Gualdrón-López, Melisa|||0000-0002-8202-6751
  • Ayllon-Hermida, Alberto|||0000-0002-9566-6934
  • Cortés Serra, Núria|||0000-0001-5396-3757
  • Resa-Infante, Patricia|||0000-0002-1727-592X
  • Bech-Serra, Joan-Josep|||0000-0003-3486-781X
  • Aparici-Herraiz, Iris|||0000-0002-6014-8221
  • Nicolau Fernández, Marc|||0000-0001-7211-796X
  • Erkizia, Itziar|||0000-0003-1244-8972
  • Gutierrez-Chamorro, Lucia
  • Marfil, Sílvia|||0000-0003-0139-5000
  • Pradenas, Edwards|||0000-0001-5162-8920
  • Ávila Nieto, Carlos
  • Cucurull, Bernat
  • Montaner-Tarbés, Sergio
  • Muelas, Magdalena
  • Sotil, Ruth
  • Ballana, Ester|||0000-0002-5215-7363
  • Urrea, Víctor|||0000-0002-2577-856X
  • Fraile, Lorenzo|||0000-0002-8980-5862
  • Montoya, Maria|||0000-0002-5703-7360
  • Vergara-Alert, Júlia|||0000-0001-7484-444X
  • Segalés Coma, Joaquim|||0000-0002-1539-7261
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Izquierdo Useros, Nuria|||0000-0002-1039-1821
  • Blanco, Julià|||0000-0002-2225-0217
  • Fernandez-Becerra, Carmen|||0000-0001-5154-0013
  • De La Torre, Carolina
  • Pinazo, Maria-Jesus|||0000-0002-4237-1075
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
  • Del Portillo, Hernando A.|||0000-0002-5278-3452
Extracellular vesicles (EVs) released by virus-infected cells have the potential to encapsulate viral peptides, a characteristic that could facilitate vaccine development. Furthermore, plasma-derived EVs may elucidate pathological changes occurring in distal tissues during viral infections. We hypothesized that molecular characterization of EVs isolated from COVID-19 patients would reveal peptides suitable for vaccine development. Blood samples were collected from three cohorts: severe COVID-19 patients (G1), mild/asymptomatic cases (G2), and SARS-CoV-2-negative healthcare workers (G3). Samples were obtained at two time points: during the initial phase of the pandemic in early 2020 (m0) and eight months later (m8). Clinical data analysis revealed elevated inflammatory markers in G1. Notably, non-vaccinated individuals in G1 exhibited increased levels of neutralizing antibodies at m8, suggesting prolonged exposure to viral antigens. Proteomic profiling of EVs was performed using three distinct methods: immunocapture (targeting CD9), ganglioside-capture (utilizing Siglec-1) and size-exclusion chromatography (SEC). Contrary to our hypothesis, this analysis failed to identify viral peptides. These findings were subsequently validated through Western blot analysis targeting the RBD of the SARS-CoV-2 Spike protein's and comparative studies using samples from experimentally infected Syrian hamsters. Furthermore, analysis of the EV cargo revealed a diverse molecular profile, including components involved in the regulation of viral replication, systemic inflammation, antigen presentation, and stress responses. These findings underscore the potential significance of EVs in the pathogenesis and progression of COVID-19.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening Protocol

  • Gutiérrez, Félix|||0000-0002-9485-6867
  • López, Leandro
  • Galera, Carlos
  • Tiraboschi, Juan Manuel|||0000-0002-0073-873X
  • Portu, Joseba
  • García-Fraile Fraile, Lucio|||0000-0002-2512-6107
  • García del Toro, Miguel
  • Bernal, Enrique|||0000-0002-4041-0579
  • Rivero Román, Antonio|||0000-0002-8643-4250
  • García-Abellán, Javier|||0000-0002-5217-3726
  • Flores, Juan
  • González Cordón, Ana|||0000-0002-0894-3711
  • Martínez, Onofre
  • Bravo Urbieta, Joaquín|||0000-0003-2079-0305
  • Rosado, Dácil
  • Montero, Marta|||0000-0002-3432-5394
  • Sirera, Guillem|||0000-0003-4014-9355
  • Torralba, Miguel|||0000-0003-2166-7405
  • Galindo Puerto, María José
  • Macías, Juan|||0000-0002-4778-790X
  • Gónzalez Cuello, Inmaculada|||0000-0001-8519-7823
  • Boix, Vicente|||0000-0002-7015-3948
  • Vivancos, María Jesús
  • Dios Diez, Paula|||0000-0003-2700-6595
  • Blanco, José Ramón|||0000-0002-4268-0150
  • Padilla Urrea, Sergio|||0000-0002-8420-7310
  • Fernández-González, Marta|||0000-0001-9949-8504
  • Gutiérrez Ortiz de la Tabla, Ana|||0000-0002-6080-0195
  • Martínez, Esteban|||0000-0002-6911-8846
  • Masiá, Mar|||0000-0001-9878-2458
Background. Non-AIDS defining malignancies present a growing challenge for persons with human immunodeficiency virus (HIV, PWH), yet tailored interventions for timely cancer diagnosis are lacking. The Spanish IMPAC-Neo protocol was designed to compare two comprehensive cancer screening strategies integrated into routine HIV care. This study reports baseline data on the prevalence and types of precancerous lesions and early-stage cancer among participants at enrolment. Acceptability of the procedure was additionally assessed. Methods. Cross-sectional analysis of a comprehensive screening protocol to detect precancer and cancer. The readiness of healthcare providers to implement the protocol was evaluated using a validated 4-item survey. Results. Among the 1430 enrolled PWH, 1172 underwent 3181 screening tests, with positive findings in 29.4% of cases, leading to further investigation in 20.7%. Adherence to the protocol was 84%, with HIV providers expressing high acceptability (97.1%), appropriateness (91.4%), and feasibility (77.1%). A total of 145 lesions were identified in 109 participants, including 60 precancerous lesions in 35 patients (3.0%), 9 early-stage cancers in 9 patients (0.8%), and 76 low-risk lesions in 65 subjects (5.5%). Adverse events related to screening occurred in 0.8% of participants, all mild. The overall prevalence of cancer precursors or early-stage cancer was 3.8% (95% confidence interval [CI], 2.74%-5.01%), with highest rates observed in individuals screened for anal and colorectal cancers. Conclusions. The baseline comprehensive cancer screening protocol of the IMPAC-Neo study successfully identified a significant proportion of PWH with precancerous lesions and early-stage cancer. High adherence rates and positive feedback from providers suggest effective implementation potential in real-world healthcare settings.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Unprecedented selectivity for homologous lectin targets, differential targeting of the viral receptors L-SIGN and DC-SIGN

  • Delaunay, Clara
  • Pollastri, Sara
  • Thepaut, Michel
  • Cavazzoli, Gianluca
  • Belvisi, Laura
  • Bouchikri, Clementine
  • Labiod, Nuria
  • Lasala, Fatima
  • Gimeno, Ana
  • Franconetti, Antonio|||0000-0002-7972-8795
  • Jiménez Barbero, Jesús|||0000-0001-5421-8513
  • Arda, Ana
  • Delgado, Rafael
  • Bernardi, Anna
  • Fieschi, Franck
DC-SIGN (CD209) and L-SIGN (CD209L) are two C-type lectin receptors (CLRs) that facilitate SARS-CoV-2 infections as viral co-receptors. SARS-CoV-2 manipulates both DC-SIGN and L-SIGN for enhanced infection, leading to interest in developing receptor antagonists. Despite their structural similarity (82% sequence identity), they function differently. DC-SIGN, found in dendritic cells, shapes the immune response by recognizing pathogen-associated carbohydrate patterns. In contrast, L-SIGN, expressed in airway epithelial endothelial cells, is not directly involved in immunity. COVID-19's primary threat is the hyperactivation of the immune system, potentially reinforced if DC-SIGN engages with exogenous ligands. Therefore, L-SIGN, co-localized with ACE2-expressing cells in the respiratory tract, is a more suitable target for anti-adhesion therapy. However, designing a selective ligand for L-SIGN is challenging due to the high sequence identity of the Carbohydrate Recognition Domains (CRDs) of the two lectins. We here present Man84, a mannose ring modified with a methylene guanidine triazole at position 2. It binds L-SIGN with a KD of 12.7μM ± 1 μM (ITC) and is the first known L-SIGN selective ligand, showing 50-fold selectivity over DC-SIGN (SPR). The X-ray structure of the L-SIGN CRD/Man84 complex reveals the guanidinium group's role in achieving steric and electrostatic complementarity with L-SIGN. This allows us to trace the source of selectivity to a single amino acid difference between the two CRDs. NMR analysis confirms the binding mode in solution, highlighting Man84's conformational selection upon complex formation. Dimeric versions of Man84 achieve additional selectivity and avidity in the low nanomolar range. These compounds selectively inhibit L-SIGN dependent trans-infection by SARS-CoV-2 and Ebola virus. Man84 and its dimeric constructs display the best affinity and avidity reported to date for low-valency glycomimetics targeting CLRs. They are promising tools for competing with SARS-CoV-2 anchoring in the respiratory tract and have potential for other medical applications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV, an analysis of a multicentre cohort at 96 weeks

  • Suárez-García, Inés|||0000-0002-7016-716X
  • Alejos, Belén
  • Moreno Prieto, Cristina|||0000-0002-3378-3158
  • Martín Torres, Juan
  • Masiá, Mar|||0000-0001-9878-2458
  • García-Fraile Fraile, Lucio|||0000-0002-2512-6107
  • Riera, Melchor
  • Dalmau, David|||0000-0003-1936-478X
  • Rodríguez-Rosado, Rafael
  • Muga, Roberto|||0000-0001-6301-431X
  • Moreno, Santiago|||0000-0002-2843-1094
  • Jarrín, Inma|||0000-0002-7485-2252
To evaluate the long-term effectiveness, persistence and tolerability of dolutegravir (DTG)/lamivudine (3TC), compared with the most frequently prescribed first-line treatment regimens, among antiretroviral-naive people with HIV from CoRIS, a multicentre cohort in Spain, in 2018-23. We used multivariable regression models to compare viral suppression (VS) (HIV RNA viral load <50 copies/mL), change in CD4 cell counts, persistence and treatment discontinuations due to adverse events (AEs), at 96 (±24) weeks after treatment initiation. Of 2359 participants, DTG/3TC was prescribed in 472 (20.0%), bictegravir/tenofovir alafenamide (TAF)/emtricitabine (FTC) in 1134 (48.1%), DTG + tenofovir disoproxil fumarate/FTC in 300 (12.7%), DTG/abacavir/3TC in 273 (11.6%) and darunavir/cobicistat/TAF/FTC in 180 (7.6%). At 96 weeks from treatment initiation, 94.0% of participants initiating with DTG/3TC achieved VS, and the mean increase in CD4 cell counts was 295.5 cells/μL (95% CI: 269.9-321.1). During the first 96 weeks after DTG/3TC initiation, 9.8% and 1.3% discontinued their initial regimen, overall and due to AEs, respectively. In multivariable analyses, we did not find significant differences in VS or increase in CD4 cell counts among participants initiating with DTG/3TC compared with other regimens. Initiating ART with a regimen other than DTG/3TC was associated with a higher risk of treatment discontinuation, overall and due to AEs. Among treatment-naive people with HIV from this large multicentre cohort, DTG/3TC had similar effectiveness and better persistence and tolerability than those of the most frequently prescribed first-line regimens at 96 weeks.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clonal dissemination and plasmid plasticity of KPC-3-producing Klebsiella pneumoniae ST512 during a hospital outbreak in Spain

  • Riesgo-Magaña, María|||0000-0003-0825-9319
  • Moreno Mingorance, Albert|||0000-0002-3073-5046
  • Bueno, Jessica|||0000-0002-4125-8150
  • Arnal, Sara|||0000-0001-8889-6857
  • Alvarado, Elena|||0000-0003-3560-5096
  • González-López, Juanjo|||0000-0003-2419-5909
  • Seral, Cristina|||0000-0002-9742-1463
Purpose: To describe the first outbreak of KPC-3-producing Klebsiella pneumoniae ST512 in Aragón, Spain, and characterize its clinical, microbiological, and genomic features, including plasmid dynamics, resistance mechanisms, and phylogenetic context. Methods: Between July 2022 and July 2024, 130 KPC-3-producing K. pneumoniae isolates were recovered from 33 patients during an outbreak at a tertiary-care hospital in Zaragoza. Antimicrobial susceptibility testing and whole-genome sequencing were performed. Phylogenomic (SNP and cgMLST) and plasmid analyses defined clonal relatedness and plasmid structures. Comparative genomics with 985 international ST512/KPC-3 genomes determined phylogeographic relationships. Results: Most cases (84.6%) were detected through active surveillance. All the isolates were resistant to β-lactams, ceftolozane/tazobactam, tobramycin and amikacin, while 64.4% remained susceptible to gentamicin. All the isolates were susceptible to cefiderocol, colistin, and tigecycline. One ceftazidime/avibactam-resistant isolate carrying bla emerged after prolonged therapy. Genomic analysis confirmed a clonal outbreak of Klebsiella pneumoniae ST512 (≤ 16 SNPs; ≤13 cgMLST allelic differences). Phylogenetic comparison showed that the isolates were genetically close to those from Italy and central Spain. All isolates carried bla within Tn4401b. Three bla plasmid structures were identified: an IncFII(K) plasmid (pHCUKPC3), a ColEST258 variant, and a novel cointegrate plasmid (pHCUKPC3co). The virulence-associated factors identified included yersiniabactin (ybt10/ICEKp4), KL107 capsular type, and O2afg O-antigen. Conclusion: This study documents the wider dissemination of ST512/KPC-3 as a high-risk clone in Spain, characterized by persistence driven by clonal dissemination, selective pressure, and plasmid plasticity. Our findings highlight the need to integrate genomic and plasmidomic surveillance to anticipate resistance evolution and contain high-risk clones.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Methods and operational framework of GALFLU: Individually randomized pragmatic controlled trial of high- versus standard-dose influenza vaccination in older adults

  • Mallah, Narmeen
  • Pardo Seco, Jacobo José
  • Rodríguez-Tenreiro Sánchez, Carmen
  • Giné Vázquez, Iago
  • Mirás Carballal, Susana
  • Piñeiro Sotelo, Marta
  • Cribeiro González, Martín
  • Conde Pájaro, Mónica
  • González Pérez, Juan Manuel
  • Razzini, Josefina Lorena
  • Rivero Calle, Irene
  • Dacosta Urbieta, Ana Isabel
  • Harris, Rebecca C.
  • Loiacono, Matthew M.
  • van Aalst, Robertus
  • Farre, Joan Manel
  • Dufournet, Marine
  • Johansen, Niklas Dyrby
  • Modin, Daniel
  • Biering-Sørensen, Tor
  • Durán Parrondo, Carmen
  • Martinón Torres, Federico
Introduction: Optimizing influenza vaccination in older adults is a public health priority. While high-dose inactivated influenza vaccines (HD-IIV) have shown superior immunogenicity and efficacy over standard-dose vaccines (SD-IIV), there is a shortage of large-scale, individually randomized data evaluating real-world effectiveness against severe outcomes—especially within publicly funded health systems. Methods: GALFLU is a pragmatic, individually randomized, open-label clinical trial comparing HD-IIV and SD-IIV in adults aged 65–79 years in Galicia, Spain, during the 2023–2024 and 2024–2025 influenza seasons. The trial embedded individual randomization into the regional vaccination program and exploited digital health registries for comprehensive, low-burden data collection under real-world conditions. The primary outcome is relative vaccine effectiveness (rVE) against a composite of influenza- or pneumonia-related hospitalizations. Secondary and exploratory outcomes include rVE against cardio-respiratory hospitalization, laboratory-confirmed influenza hospitalization, all-cause hospitalization, mortality, and healthcare utilization. The GALFLU protocol was approved by the Comité de ética de la investigación con medicamentos de Galicia (CEIm-G, code 2023/374). Participation was fully voluntary. Results: GALFLU demonstrated the feasibility of large-scale, pragmatic randomized controlled trials within routine clinical practice. Findings from GALFLU will be disseminated in peer-reviewed scientific journals and scientific meetings and shared with relevant authorities. Conclusions: GALFLU provides a reproducible blueprint for future pragmatic evaluations embedded in routine public health settings.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity

  • Marco, Sonia
  • Fernández-Sendin, Myriam
  • Honorato, Beatriz
  • Juanarena, Nerea
  • Sáinz, Cristina
  • Andueza San Miguel, Ainhoa
  • Gould, David J.
  • Anderson, Seth
  • Andrea, Carlos de
  • Pérez Domínguez, Paulo
  • Wong, Paolo
  • Vásquez, Carlos
  • Narinda, Irene
  • Unzu, Carmen
  • Isola, Sergio
  • Tavira, Beatriz
  • Ariz Galilea, Mikel
  • Camps, Gracián
  • Sanmamed, Miguel F.
  • Pardo, Julián
  • Labiano, Sara
  • Alonso, Marta M.
  • Marco-Sanz, Javier
  • Guruceaga, Elizabeth
  • Collantes, María
  • Simón, Jon Ander
  • Peñuelas, Iván
  • Fernández Irigoyen, Joaquín
  • Santamaría Martínez, Enrique
  • Prieto, Jesús
  • Dubrot, Juan
Radiotherapy (RT) can prime the immune system against cancer but often fails to generate effective antitumor responses due to concomitant induction of immunosuppressive factors. To overcome this limitation, we built upon the observation that RT enhances adeno-associated vectors (AAVs) tumor transduction through the epigenetic modification of vector episomes. We designed an AAV-based platform to deliver immunostimulatory cytokines through an interferon (IFN)-inducible promoter that allows for spatial control of transgene expression into irradiated tumors. As opposed to a constitutive system, local delivery of a vector encoding for inducible IL-12 (AAV-iIL12) achieves an efficient production of the cytokine without significant toxicity. Combination of RT and AAV-iIL12 generates a highly immunostimulatory tumor microenvironment (TME) leading to robust local and systemic antitumor responses in an IFNγ- and FAS-dependent manner, able to overcome common immune-evasion mechanisms. Our work shows that radiation coupled with AAV-based immune-gene delivery is an efficient and safe approach to treat cancer., This work was supported by grants PID2024-160227OB-I00 (funded by MICIU/AEI/10.13039/501100011033 and FEDER, EU), NAIARA Project (ref. 0011-1411-2025-000144, funded by Gobierno de Navarra and FEDER 2021-2027), PID2020-113963RBI00 from AEI, Aragon Government (B29-20R) and CIBERINFEC/Instituto de Salud Carlos III, (CB21/13/00087).
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Survey of severe acute respiratory syndrome coronavirus 2 in captive and free-ranging wildlife from Spain

  • Serra Gironella, Joan
  • Cano-Terriza, David
  • Caballero-Gómez, Javier
  • Beato-Benítez, Adrián
  • Fernández, Antonio
  • García-Párraga, Daniel
  • Domingo, Mariano
  • Sierra, Cecilia
  • Canales, Rocío
  • Borragan, Santiago
  • de la Riva‑Fraga, Manuel
  • Molina‑López, Rafael
  • Cabezón, Óscar
  • Puig‑Ribas, Maria
  • Espunyes, Johan
  • Vázquez‑Calero, Daniel B.
  • Vergara-Alert, Júlia
  • García‑Bocanegra, Ignacio
  • Segalés, Joaquim
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), considered a zoonotic agent of wildlife origin, can infect various animal species, including wildlife in free-range and captive environments. Detecting susceptible species and potential reservoirs is crucial for preventing the transmission, spread, genetic evolution, and further emergence of viral variants that are major threats to global health. This study aimed to detect exposure or acute infection by SARS-CoV-2 in 420 animals from 40 different wildlife species, including terrestrial and aquatic mammals, from different regions of Spain during the 2020-2023 coronavirus disease 19 (COVID-19) pandemic. In total, 8/137 animals were positive for SARS-CoV-2 antibodies against the receptor binding domain and/or viral nucleoprotein according to independent ELISAs. However, only one ELISA-positive sample of a captive bottlenose dolphin (Tursiops truncatus) tested positive for SARS-CoV-2 neutralizing antibodies with a low titre (SNT50 38.15) according to a virus neutralization test. Cetaceans are expected to have a high risk of infection with SARS-CoV-2 according to early predictive studies due to the similarity of their angiotensin converting enzyme 2 cell receptor to that of humans. Moreover, of 283 animals analysed for SARS-CoV-2 RNA using RT-qPCR, none tested positive. Our results reinforce the importance of considering cetaceans at risk for SARS-CoV-2 infection and support taking preventive biosecurity measures when interacting with them, especially in the presence of individuals with suspected or confirmed COVID-19. Although most animals in this study tested negative for acute infection or viral exposure, ongoing surveillance of wildlife species and potentially susceptible animals is important to prevent future spillover events and detect potential novel reservoirs., This research was partially supported by the Innovation and Transfer Plan of the University of Cordoba (UCO-SOCIAL-INNOVA) and CIBER—Consorcio Centro de Investigación Biomédica en Red—(CB2021/13/00083), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea–Next Generation EU. L. Fernández-Bastit was supported by the crowdfunding initiative # Yomecorono [57]. A. Beato-Benítez holds a PhD contract supported by the Andalusian System of Knowledge. M. P. Ribas was funded through the 2021 FI Scholarship, Departament de Recerca i Universitats, Generalitat de Catalunya, Spain (FI_B 00171)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Assessment of SARS-CoV-2 exposure in exotic pets in Spain

  • Cano-Terriza, David
  • Fernández-Bastit, Leira
  • Vergara-Alert, Júlia
  • Váquez-Calero, Daniel B.
  • Castro-Scholten, Sabrina
  • Caballero-Gomez, Javier
  • García-Bocanegra, Ignacio
  • Segalés, Joaquim
Evidence of SARS-CoV-2 infections in different animal species raises concerns about the potential for animal reservoirs and transmission to humans. Here, we evaluate the exposure of exotic pet species to this virus throughout the early years of the pandemic (2020 – 2022) in southern Spain. A total of 180 exotic pets (126 domestic rabbits, 31 ferrets, and 23 rodents) were analyzed for antibodies against SARS-CoV-2 using two different ELISAs. ELISA-positive sera were subsequently tested for specific neutralizing antibodies (nAbs) using the virus neutralization test (VNT). Only one brown rat (Rattus norvegicus), representing 0.6 % of the total, tested positive by ELISA, yet showed negative result for SARS-CoV-2 nAbs by VNT. Our results suggest a very limited risk of SARS-CoV-2 transmission among humans and sympatric exotic pet species in the study region. However, the virus's potential for interspecies transmission emphasizes the need for ongoing surveillance, especially in settings with frequent human-animal interactions, to avoid potential virus evolution, the emergence of new animal reservoirs, and spillover events., This research was partially supported by the Innovation and Transfer Plan of the University of Cordoba and CIBER -Consorcio Centro de Investigación Biomédica en Red- (CB2021/13/00083), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea–NextGenerationEU. Leira Fernández-Bastit was supported by the crowdfunding initiative #Yomecorono, available online at: https://www.yomecorono.com (accessed on 9 December 2024). Sabrina Castro-Scholten holds a PhD contract supported by the Spanish Ministry of Universities (FPU19/06026)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 in Captive Nonhuman Primates, Spain, 2020–2023

  • Cano-Terriza, David
  • Beato-Benítez, Adrián
  • Fernández-Bastit, Leira
  • Segalés, Joaquim
  • Vergara-Alert, Júlia
  • Martínez-Nevado, Eva
  • Carretero, Andrea
  • Crailsheim, Dietmar
  • Soriano, Pilar
  • Planas, Javier
  • Torro, Mario
  • García-Bocanegra, Ignacio
We conducted a serologic and molecular study to assess exposure of captive nonhuman primates (NHPs) to SARS-CoV-2 in Spain during the 2020–2023 COVID-19 pandemic. We found limited exposure of NHPs to SARS-CoV-2. Biosafety measures must be strictly maintained to avoid SARS-CoV-2 reverse-zoonotic transmission in the human–NHP interface., We thank Bioparc Fuengirola, Bioparc Valencia, Centro de Conservación Zoo Córdoba, Faunia, Marcelle Naturaleza, MundoMar Benidorm, Parque de la Naturaleza de Cabárceno, Selwo Aventura, Terra Natura Murcia, Zoo de Santillana del Mar, and Centro de Conservación de la Biodiversidad Zoobotánico Jerez-Alberto Durán for providing the valuable samples. This research was partially supported by the Innovation and Transfer Plan of the University of Cordoba and CIBER, Consorcio Centro de Investigación Biomédica en Red (CB2021/13/00083), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea–NextGenerationEU. A.B.-B. is a PhD. candidate supported by the Andalusian System of Knowledge., info:eu-repo/semantics/publishedVersion
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Emergence of Carbapenemase Genes in Gram-Negative Bacteria Isolated from the Wastewater Treatment Plant in A Coruña, Spain

  • Nasser-Ali, Mohammed
  • Aja-Macaya, Pablo
  • Conde-Pérez, Kelly
  • Trigo Tasende, Noelia
  • Rumbo-Feal, Soraya
  • Fernández González, Ana
  • Bou, Germán
  • Poza, Margarita
  • Vallejo, J. A.
[Abstract] Wastewater treatment plants (WWTPs) are recognized as important niches of antibiotic-resistant bacteria that can be easily spread to the environment. In this study, we collected wastewater samples from the WWTP of A Coruña (NW Spain) from April 2020 to February 2022 to evaluate the presence of Gram-negative bacteria harboring carbapenemase genes. Bacteria isolated from wastewater were classified and their antimicrobial profiles were determined. In total, 252 Gram-negative bacteria carrying various carbapenemase genes were described. Whole-genome sequencing was conducted on 55 selected carbapenemase producing isolates using Oxford Nanopore technology. This study revealed the presence of a significant population of bacteria carrying carbapenemase genes in WWTP, which constitutes a public health problem due to their risk of dissemination to the environment. This emphasizes the usefulness of WWTP monitoring for combating antibiotic resistance. Data revealed the presence of different types of sequences harboring carbapenemase genes, such as blaKPC-2, blaGES-5, blaGES-6, blaIMP-11, blaIMP-28, blaOXA-24, blaOXA-48, blaOXA-58, blaOXA-217, and blaVIM-2. Importantly, the presence of the blaKPC-2 gene in wastewater, several months before any clinical case was detected in University Hospital of A Coruña, suggests that wastewater-based epidemiology can be used as an early warning system for the surveillance of antibiotic-resistant bacteria., The present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the project PI20/00413, co-funded by the European Union (EU) to M.P. and by CIBER de Enfermedades Infecciosas: CIBERINFEC, ISCIII (CB21/13/00055) to G.B and M.P.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

The Multispecies Microbial Cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a Precision Biomarker for Colorectal Cancer Diagnosis

  • Ladra, Susana
  • Poza, Margarita
  • Conde-Pérez, Kelly
  • Aja-Macaya, Pablo
  • Buetas, Elena
  • Trigo Tasende, Noelia
  • Nasser-Ali, Mohammed
  • Rumbo-Feal, Soraya
  • Nión, P.
  • Martin-De Arribas, E.
  • Estévez, Lara
  • Otero Alén, Begoña
  • Noguera, José
  • Concha López, Ángel
  • Pardiñas López, Simón
  • Carda-Diéguez, Miguel
  • Gómez-Randulfe, Igor
  • Martínez-Lago, Nieves
  • Antón-Aparicio, Luis M.
  • Bou, Germán
  • Mira, Alex
  • Vallejo, J. A.
[Abstract] The incidence of colorectal cancer (CRC) has increased worldwide, and early diagnosis is crucial to reduce mortality rates. Therefore, new noninvasive biomarkers for CRC are required. Recent studies have revealed an imbalance in the oral and gut microbiomes of patients with CRC, as well as impaired gut vascular barrier function. In the present study, the microbiomes of saliva, crevicular fluid, feces, and non-neoplastic and tumor intestinal tissue samples of 93 CRC patients and 30 healthy individuals without digestive disorders (non-CRC) were analyzed by 16S rRNA metabarcoding procedures. The data revealed that Parvimonas, Fusobacterium, and Bacteroides fragilis were significantly over-represented in stool samples of CRC patients, whereas Faecalibacterium and Blautia were significantly over-abundant in the non-CRC group. Moreover, the tumor samples were enriched in well-known periodontal anaerobes, including Fusobacterium, Parvimonas, Peptostreptococcus, Porphyromonas, and Prevotella. Co-occurrence patterns of these oral microorganisms were observed in the subgingival pocket and in the tumor tissues of CRC patients, where they also correlated with other gut microbes, such as Hungatella. This study provides new evidence that oral pathobionts, normally located in subgingival pockets, can migrate to the colon and probably aggregate with aerobic bacteria, forming synergistic consortia. Furthermore, we suggest that the group composed of Fusobacterium, Parvimonas, Bacteroides, and Faecalibacterium could be used to design an excellent noninvasive fecal test for the early diagnosis of CRC. The combination of these four genera would significantly improve the reliability of a discriminatory test with respect to others that use a single species as a unique CRC biomarker., The authors want to appreciate the good disposition of all the CRC patients for collaborating with us. We would like to thank Gema Carro Díaz and Montserrat Ingelmo Sánchez for their assistance during patients' recruitment time and also during tissue sample collection. This work would not be possible without the support of professionals from the Microbiology, Surgery, Pathology and Oncology Services and Biobank of CHUAC (Spain). The present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the project PI20/00413, cofunded by the European Union (EU) to MP. The whole work has been also supported by the project RTI2018-102032-B-I00 from the Spanish Ministry of Science and Innovation to AM and by CIBER INFEC ISCIII (CB21/13/00055) to GB and MP Biobank of A Coruña was supported by ISCIII-Fondos FEDER (EU) by grant PT20/00128. KC-P was financially supported by the Spanish Association against Cancer (AECC). EB was supported by a grant from the Spanish Ministry of Science and Innovation PRE2019-088126. SL and EM-DA were supported by grants from GAIN (Xunta de Galicia, Spain) with references ED431C 2021/53 and ED431G 2019/01., Xunta de Galicia; ED431C 2021/53, Xunta de Galicia; ED431G 2019/01
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Parvimonas Micra Can Translocate From the Subgingival Sulcus of the Human Oral Cavity to Colorectal Adenocarcinoma

  • Conde-Pérez, Kelly
  • Buetas, Elena
  • Aja-Macaya, Pablo
  • Martin-De Arribas, E.
  • Iglesias Corrás, Iago
  • Trigo Tasende, Noelia
  • Nasser-Ali, Mohammed
  • Estévez, Lara
  • Rumbo-Feal, Soraya
  • Otero Alén, Begoña
  • Noguera, José
  • Concha López, Ángel
  • Pardiñas López, Simón
  • Carda-Diéguez, Miguel
  • Gómez-Randulfe, Igor
  • Martínez-Lago, Nieves
  • Ladra, Susana
  • Antón-Aparicio, Luis M.
  • Bou, Germán
  • Mira, Alex
  • Vallejo, J. A.
  • Poza, Margarita
[Abstract] Oral and intestinal samples from a cohort of 93 colorectal cancer (CRC) patients and 30 healthy controls (non-CRC) were collected for microbiome analysis. Saliva (28 non-CRC and 94 CRC), feces (30 non-CRC and 97 CRC), subgingival fluid (20 CRC), and tumor tissue samples (20 CRC) were used for 16S metabarcoding and/or RNA sequencing (RNAseq) approaches. A differential analysis of the abundance, performed with the ANCOM-BC package, adjusting the P-values by the Holm-Bonferroni method, revealed that Parvimonas was significantly over-represented in feces from CRC patients (P-value < 0.001) compared to healthy controls. A total of 11 Parvimonas micra isolates were obtained from the oral cavity and adenocarcinoma of CRC patients. Genome analysis identified a pair of isolates from the same patient that shared 99.2% identity, demonstrating that P. micra can translocate from the subgingival cavity to the gut. The data suggest that P. micra could migrate in a synergistic consortium with other periodontal bacteria. Metatranscriptomics confirmed that oral bacteria were more active in tumor than in non-neoplastic tissues. We suggest that P. micra could be considered as a CRC biomarker detected in non-invasive samples such as feces., This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project PI20/00413 and co-funded by the European Union to MP. The work has been also supported by the project RTI2018-102032-B-I00 from the Spanish Ministry of Science and Innovation to AM and by the CIBER INF ISCIII (CB21/13/00055) to GB and MP. Biobank of University Hospital Complex of A Coruña was supported by Instituto de Salud Carlos III – Fondos FEDER (EU) by grant PT20/00128. K. Conde-Pérez was financially supported with a predoctoral fellowship by the Asociación Española Contra el Cáncer (AECC). E. Buetas is supported by a grant from the Spanish Ministry of Science and Innovation with the reference PRE2019-088126. S. Ladra, E. Martin-De Arribas and Iago Iglesias-Corrás are supported by grants from GAIN (Xunta de Galicia, Spain) with references ED431C 2021/53 and ED431G, Xunta de Galicia; ED431C 2021/53, Xunta de Galicia; ED431G
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study

  • Lasarte-Monterrubio, Cristina
  • Guijarro, Paula
  • Alonso-García, Isaac
  • Outeda-García, Michelle
  • Maceiras, Romina
  • González-Pinto, Lucía
  • Martínez Guitián, Marta
  • Fernández-Lozano, Carlos
  • Vázquez-Ucha, Juan Carlos
  • Bou, Germán
  • Arca-Suárez, Jorge
  • Beceiro Casas, Alejandro
[Abstract]: Background: As increasing antibiotic resistance in Acinetobacter baumannii poses a global healthcare challenge, understanding its evolution is crucial for effective control strategies. Aim: We aimed to evaluate the epidemiology, antimicrobial susceptibility and main resistance mechanisms of Acinetobacter spp. in Spain in 2020, and to explore temporal trends of A. baumannii. Methods: We collected 199 single-patient Acinetobacter spp. clinical isolates in 2020 from 18 Spanish tertiary hospitals. Minimum inhibitory concentrations (MICs) for nine antimicrobials were determined. Short-read sequencing was performed for all isolates, and targeted long-read sequencing for A. baumannii. Resistance mechanisms, phylogenetics and clonality were assessed. Findings on resistance rates and infection types were compared with data from 2000 and 2010. Results: Cefiderocol and colistin exhibited the highest activity against A. baumannii, although colistin susceptibility has significantly declined over 2 decades. A. non-baumannii strains were highly susceptible to most tested antibiotics. Of the A. baumannii isolates, 47.5% (56/118) were multidrug-resistant (MDR). Phylogeny and clonal relationship analysis of A. baumannii revealed five prevalent international clones, notably IC2 (ST2, n = 52; ST745, n = 4) and IC1 (ST1, n = 14), and some episodes of clonal dissemination. Genes blaOXA-23, blaOXA-58 and blaOXA-24/40 were identified in 49 (41.5%), eight (6.8%) and one (0.8%) A. baumannii isolates, respectively. ISAba1 was found upstream of the gene (a blaOXA-51-like) in 10 isolates. Conclusions: The emergence of OXA-23-producing ST1 and ST2, the predominant MDR lineages, shows a pivotal shift in carbapenem-resistant A. baumannii (CRAB) epidemiology in Spain. Coupled with increased colistin resistance, these changes underscore notable alterations in regional antimicrobial resistance dynamics., This work was supported by Projects PI20/01212 and PI23/00851 awarded to AB, Project PI21/00704 awarded to GB, and Project PI22/01212 awarded to JA-S, funded by the Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. The work was also supported by CIBER-Consorcio Centro de Investigación Biomédica en Red- de Enfermedades Infecciosas, Instituto de Salud Carlos III (CB21/13/00055), Ministerio de Ciencia e Innovación and Unión Europea—NextGenerationEU and by project IN607A 2020/05 (GAIN-Agencia Gallega de InnovaciónConsellería de Economía, Emprego e Industria) awarded to GB and project IN607D 2021/12 awarded to AB. JA-S was financially supported by the Juan Rodés program (ISCIII, JR21/00026), JCV-U was financially supported by IN606B-2022/009 (Xunta de Galicia), CL-M was financially supported by PI20/01212 (ISCIII), PG-S was financially supported by IN606A 2021/021 Grant (Xunta de Galicia). MO was financially supported by IN607D 2021/12. IA-G was financially supported by the Rio Hortega program (ISCIII, CM21/00076). MM-G was financially supported by RSU.UDC.M505 (Ministerio de Universidades)., Xunta de Galicia; IN607A 2020/05, Xunta de Galicia; IN607D 2021/12, Xunta de Galicia; IN606B-2022/009, Xunta de Galicia; IN606A 2021/021, Xunta de Galicia; IN607D 2021/12, Universidade da Coruña; RSU.UDC.M505
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Nanopore full length 16S rRNA gene sequencing increases species resolution in bacterial biomarker discovery

  • Aja-Macaya, Pablo
  • Conde-Pérez, Kelly
  • Noelia Trigo-Tasende
  • Nasser-Ali, Mohammed
  • Nión, P.
  • Rumbo-Feal, Soraya
  • Ladra, Susana
  • Bou, Germán
  • Vallejo, J. A.
  • Poza, Margarita
Raw sequence reads generated from 16S rRNA gene sequencing by MiSeq (Illumina-V3V4) and MinION (ONT-V1V9, Dorado sup v4.1.0) are available in the NCBI SRA database under bioproject PRJNA911189. Used scripts and additional documentation are available at https://github.com/Pablo-Aja-Macaya/CRC-ONT16S., [Abstract]: Discovery of disease-related bacterial biomarkers could be a useful approach for early prevention or diagnosis of various afflictions, such as colorectal cancer. This typically involves analyzing small regions of the 16S rRNA gene (e.g. V3V4) through short-read technologies like Illumina, obtaining genus-level results. However, recent developments in third-generation sequencing, such as Oxford Nanopore Technologies (ONT)’s new R10.4.1 chemistry and its improved basecalling models, are beginning to allow for a more complete and accessible species-level analysis through full-length 16S rRNA gene sequencing (spanning regions V1-V9). Thus, the goal of this study was to compare and evaluate both approaches, using colorectal cancer biomarker discovery as a representative case. This was achieved through the analysis of feces from 123 subjects, comparing both methods (Illumina-V3V4 with DADA2 and QIIME2 vs. ONT-V1V9 with Emu), multiple Dorado basecalling models (fast, hac and sup) and multiple databases (SILVA vs. Emu’s Default database). Basecalling models broadly resulted in similar taxonomic output, but had significantly higher observed species and different taxonomic identification the lower the basecalling quality (p-value<0.05). Database choice with Emu influenced the identified species greatly, with Emu’s Default database obtaining significantly higher diversity and identified species than SILVA (p-value<0.05). However, it overconfidently classified at times what should be an unknown species as the closest match due to its database structure. Bacterial abundance between Illumina-V3V4 and ONT-V1V9 at the genus level correlated well (R2 0.8). Nanopore sequencing identified more specific bacterial biomarkers for colorectal cancer than those obtained with Illumina, such as Parvimonas micra, Fusobacterium nucleatum, Peptostreptococcus stomatis, Peptostreptococcus anaerobius, Gemella morbillorum, Clostridium perfringens, Bacteroides fragilis and Sutterella wadsworthensis. Prediction of colorectal cancer through manual feature selection and machine learning resulted in an AUC of 0.87 with 14 species or 0.82 with just 4 species (P. micra, F. nucleatum, B. fragilis and Agathobaculum butyriciproducens). Full 16S rRNA V1V9 sequencing through Oxford Nanopore and its new R10.4.1 chemistry achieved accurate species-level bacterial identification, facilitating the discovery of more precise disease-related biomarkers and increasing the taxonomic fidelity of future microbiome analyses., This study has been funded by the Instituto de Salud Carlos III (ISCIII), through the projects PI20/00413 and PI23/00696, cofunded by the European Union (EU) to MP. Also, the work was funded by the project IN607A2024/09 from Xunta de Galicia (Spain) to GB. Additionally, it has been supported by the project RTI2018-102032-B-I00 from the Spanish Ministry of Science and Innovation to AM and by CIBER INFEC ISCIII (CB21/13/00055) to GB and MP. KC-P was financially supported by the Spanish Association against Cancer (AECC) from December 2019 to December 2023. Additionally, this work, integrated into the framework of PERTE for Vanguard Health, has been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Galicia within the framework of the Biotechnology Plan Applied to Health to SL., Xunta de Galicia; IN607A2024/09
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients

  • Valle-Millares, Daniel
  • Brochado-Kith, Óscar
  • Martín-Carbonero, Luz
  • Domínguez-Domínguez, Lourdes
  • Ryan, Pablo
  • De Los Santos, Ignacio
  • De la Fuente, Sara
  • Castro, Juan M.
  • Lagarde, María
  • Cuevas, G.
  • Mayoral-Muñoz, Mario
  • Matarranz, Mariano
  • Díez, Victorino
  • Gómez-Sanz, Alicia
  • Martínez-Román, Paula
  • Crespo-Bermejo, Celia
  • Palladino, Claudia
  • Muñoz Muñoz, María
  • Jiménez-Sousa, María Angeles
  • Resino, Salvador
  • Briz, Verónica
  • Fernández-Rodríguez, Amanda
18 Pág. Departamento de ​Mejora Genética Animal, Micro RNAs (miRNAs) are essential players in HIV and HCV infections, as both viruses modulate cellular miRNAs and interact with the miRNA-mediated host response. We aim to analyze the miRNA profile of HIV patients with different exposure to HCV to explore specific signatures in the miRNA profile of PBMCs for each type of infection. We massively sequenced small RNAs of PBMCs from 117 HIV+ infected patients: 45 HIV+ patients chronically infected with HCV (HIV/HCV+), 36 HIV+ that spontaneously clarified HCV after acute infection (HIV/HCV-) and 36 HIV+ patients without previous HCV infection (HIV). Thirty-two healthy patients were used as healthy controls (HC). Differential expression analysis showed significantly differentially expressed (SDE) miRNAs in HIV/HCV+ (n = 153), HIV/HCV- (n = 169) and HIV (n = 153) patients. We found putative dysregulated pathways, such as infectious-related and PI3K signaling pathways, common in all contrasts. Specifically, putatively targeted genes involved in antifolate resistance (HIV/HV+), cancer-related pathways (HIV/HCV-) and HIF-signaling (HIV) were identified, among others. Our findings revealed that HCV strongly influences the expression profile of PBMCs from HIV patients through the disruption of its miRNome. Thus, different HCV exposure can be identified by specific miRNA signatures in PBMCs., This work has been supported by grants from Institute of Health Carlos III, [PI15CIII/00031 and PI18CIII/00020/ to AFR and VB] and the Foundation Universidad Alfonso X el Sabio-Santander [grant number 1.010.932 to AFR] and the Spanish AIDS Research Network (RD16CIII/0002/0002), and Centro de Investigación Biomédica en Red (CIBER) en Enfermedades Infecciosas (CB21/13/00044). AFR is supported by the Miguel Servet programme from Fondo de Investigación Sanitaria (ISCIII) [CP14/CIII/00010 and CPII20CIII/0001], Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Proteogenomic Approach to Unravel New Proteins Encoded in the Leishmania donovani (HU3) Genome

  • Adán-Jiménez, Javier
  • Sánchez-Salvador, Alejandro
  • Morato-López, Esperanza
  • Solana, José Carlos
  • Aguado, Begoña
  • Requena, José María
The high-throughput proteomics data generated by increasingly more sensible mass spectrometers greatly contribute to our better understanding of molecular and cellular mechanisms operating in live beings. Nevertheless, proteomics analyses are based on accurate genomic and protein annotations, and some information may be lost if these resources are incomplete. Here, we show that most proteomics data may be recovered by interconnecting genomics and proteomics approaches (i.e., following a proteogenomic strategy), resulting, in turn, in an improvement of gene/protein models. In this study, we generated proteomics data from Leishmania donovani (HU3 strain) promastigotes that allowed us to detect 1908 proteins in this developmental stage on the basis of the currently annotated proteins available in public databases. However, when the proteomics data were searched against all possible open reading frames existing in the L. donovani genome, twenty new protein-coding genes could be annotated. Additionally, 43 previously annotated proteins were extended at their N-terminal ends to accommodate peptides detected in the proteomics data. Also, different post-translational modifications (phosphorylation, acetylation, methylation, among others) were found to occur in a large number of Leishmania proteins. Finally, a detailed comparative analysis of the L. donovani and Leishmania major experimental proteomes served to illustrate how inaccurate conclusions can be raised if proteomes are compared solely on the basis of the listed proteins identified in each proteome. Finally, we have created data entries (based on freely available repositories) to provide and maintain updated gene/protein models. Raw data are available via ProteomeXchange with the identifier PXD051920, This research was supported by the Spanish Ministerio de Ciencia, Innovación (MICINN), Agencia Estatal de Investigación (AEI), grant number PID2020-117916RB-I00/AEI/10.13039/501100011033 and Instituto de Salud Carlos III, grant CB21/13/00018 (CIBERINFEC). The CBM receives an institutional grant from the Fundación Ramón Areces. The CBM is a Severo Ochoa Center of Excellence (grant CEX2021-001154-S), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001154-S), Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer

  • Gascón-Ruiz, Marta
  • Ramírez-Labrada, Ariel
  • Lastra, Rodrigo
  • Martínez-Lostao, Luis
  • Paño-Pardo, J. Ramón
  • Sesma, Andrea
  • Zapata-García, María
  • Moratiel, Alba
  • Quílez, Elisa
  • Torres-Ramón, Irene
  • Yubero, Alfonso
  • Domingo, María Pilar
  • Esteban, Patricia
  • Gálvez, Eva M.
  • Pardo, Julián
  • Isla, Dolores
(1) Despite the effectiveness of immune checkpoint inhibitors (ICIs) in lung cancer, there is a lack of knowledge about predictive biomarkers. The objective of our study is to analyze different subsets of T-lymphocytes and natural killer (NK) cells as predictive biomarkers in a cohort of patients with nonsmall cell lung cancer (NSCLC) treated with ICI. (2) This is an observational, prospective study with 55 NSCLC patients treated with ICI. A total of 43 T and NK cell subsets are analyzed in peripheral blood, including the main markers of exhaustion, differentiation, memory, activation, and inhibition. (3) Regarding the descriptive data, Granzyme B+CD4+ Treg lymphocytes stand out (median 17.4%), and within the NK populations, most patients presented cytotoxic NK cells (CD56+CD3−CD16+GranzymeB+; median 94.8%), and about half of them have highly differentiated adaptive-like NK cells (CD56+CD3−CD16+CD57+ (mean 59.8%). A statistically significant difference was observed between the expression of PD1 within the CD56bright NK cell subpopulation (CD56+CD3−CD16−PD-1+) (p = 0.047) and a better OS. (4) Circulating immune cell subpopulations are promising prognostic biomarkers for ICI. Pending on validation with a larger sample, here we provide an analysis of the major circulating T and NK cell subsets involved in cancer immunity, with promising results despite a small sample size.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung

  • Moreo, Eduardo
  • Jarit-Cabanillas, Aitor
  • Robles-Vera, Iñaki
  • Uranga, Santiago
  • Guerrero, Claudia
  • Gómez, Ana Belén
  • Mata-Martínez, Pablo
  • Minute, Luna
  • Araujo-Voces, Miguel
  • Felgueres, María José
  • Esteso, Gloria
  • Uranga-Murillo, Iratxe
  • Arias, Maykel
  • Pardo, Julián
  • Martín, Carlos
  • Valés-Gómez, Mar
  • del Fresno, Carlos
  • Sancho, David
  • Aguiló, Nacho
Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer. Previous studies have demonstrated that intravenous (IV) administration of BCG is well-tolerated and effective in preventing tuberculosis infection in animals. Here, we examine IV BCG in several preclinical lung tumor models. Our findings demonstrate that BCG inoculation reduced tumor growth and prolonged mouse survival in models of lung melanoma metastasis and orthotopic lung adenocarcinoma. Moreover, IV BCG treatment was well-tolerated with no apparent signs of acute toxicity. Mechanistically, IV BCG induced tumor-specific CD8+ T cell responses, which were dependent on type 1 conventional dendritic cells, as well as NK cell-mediated immunity. Lastly, we also show that IV BCG has an additive effect on anti-PD-L1 checkpoint inhibitor treatment in mouse lung tumors that are otherwise resistant to anti-PD-L1 as monotherapy. Overall, our study demonstrates the potential of systemic IV BCG administration in the treatment of lung tumors, highlighting its ability to enhance immune responses and augment immune checkpoint blockade efficacy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Unravelling the cellular response to the SARS-COV-2 vaccine in inflammatory bowel disease patients on biologic drugs

  • Martínez-Domínguez, Samuel J.
  • García-Mateo, Sandra
  • Sainz-Arnal, Pilar
  • Martínez-García, Javier
  • Gallego-Llera, Beatriz
  • Lozano-Limones, María Jesús
  • Hidalgo, Sandra
  • Gargallo-Puyuelo, Carla J.
  • Latre-Santos, Marta
  • Nocito-Colon, Maria Mercedes Lourdes
  • Martínez-Lostao, Luis
  • Refaie, Engy
  • Arroyo-Villarino, Maria Teresa
  • del Rio-Nechaevsky, Marcela
  • Ramirez-Labrada, Ariel
  • Pardo, Julián
  • Gomollón, Fernando
  • Baptista, Pedro M.
Suboptimal vaccine response is a significant concern in patients with Inflammatory Bowel Disease (IBD) receiving biologic drugs. This single-center observational study involved 754 patients with IBD. In Phase I (October 2020-April 2021), 754 IBD participants who had not previously received the SARS-CoV-2 vaccine, underwent blood extraction to assess the seroprevalence of SARS-CoV-2 infection and IBD-related factors. Phase II (May 2021-October 2021) included a subgroup of 52 IBD participants with confirmed previous SARS-CoV-2 infection, who were studied for humoral and cellular response to the SARS-CoV-2 vaccine. In Phase I, treatment with anti-TNF was associated with lower rates of seroconversion (aOR 0.25 95% CI [0.10–0.61]). In Phase II, a significant increase in post-vaccination IgG levels was observed regardless of biologic treatment. However, patients treated with anti-TNF exhibited significantly lower IgG levels compared to those without IBD therapy (5.32 ± 2.47 vs. 7.99 ± 2.59 U/ml, p = 0.042). Following vaccination, a lymphocyte, monocyte, and NK cell activation pattern was observed, with no significant differences between patients receiving biologic drugs and those without IBD treatment. Despite lower seroprevalence and humoral response to the SARS-CoV-2 vaccine in patients treated with anti-TNF, the cellular response to the vaccine did not differ significantly from that patients without IBD therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

CAR immunotherapy for the treatment of infectious diseases: a systematic review

  • Morte-Romea, Elena
  • Pesini, Cecilia
  • Pellejero-Sagastizábal, Galadriel
  • Letona-Giménez, Santiago
  • Martínez-Lostao, Luis
  • Loscos Aranda, Silvia
  • Toyas, Carla
  • Redrado, Sergio
  • Dolader-Ballesteros, Elena
  • Arias, Maykel
  • Galvez, Eva M.
  • Sanz-Pamplona, Rebeca
  • Pardo, Julián
  • Paño-Pardo, Jose Ramón
  • Ramírez-Labrada, Ariel
Immunotherapy treatments aim to modulate the host’s immune response to either mitigate it in inflammatory/autoimmune disease or enhance it against infection or cancer. Among different immunotherapies reaching clinical application during the last years, chimeric antigen receptor (CAR) immunotherapy has emerged as an effective treatment for cancer where different CAR T cells have already been approved. Yet their use against infectious diseases is an area still relatively poorly explored, albeit with tremendous potential for research and clinical application. Infectious diseases represent a global health challenge, with the escalating threat of antimicrobial resistance underscoring the need for alternative therapeutic approaches. This review aims to systematically evaluate the current applications of CAR immunotherapy in infectious diseases and discuss its potential for future applications. Notably, CAR cell therapies, initially developed for cancer treatment, are gaining recognition as potential remedies for infectious diseases. The review sheds light on significant progress in CAR T cell therapy directed at viral and opportunistic fungal infections.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Multiparametric in vitro and in vivo analysis of the safety profile of self-assembling peptides

  • Ramirez-Labrada, Ariel
  • Santiago, Llipsy
  • Pesini, Cecilia
  • Arrieta, Marta
  • Arias, Maykel
  • Calvo Pérez, Adanays
  • Ciulla, Maria Gessica
  • Forouharshad, Mahdi
  • Pardo, Julian
  • Gálvez, Eva M.
  • Gelain, Fabrizio
Self-assembling peptides (SAPs) have gained significant attention in biomedicine because of their unique properties and ability to undergo molecular self-assembly driven by non-covalent interactions. By manipulating their composition and structure, SAPs can form well-ordered nanostructures with enhanced selectivity, stability and biocompatibility. SAPs offer advantages such as high chemical and biological diversity and the potential for functionalization. However, studies concerning its potentially toxic effects are very scarce, a limitation that compromises its potential translation to humans. This study investigates the potentially toxic effects of six different SAP formulations composed of natural amino acids designed for nervous tissue engineering and amenable to ready cross-linking boosting their biomechanical properties. All methods were performed in accordance with the relevant guidelines and regulations. A wound-healing assay was performed to evaluate how SAPs modify cell migration. The results in vitro demonstrated that SAPs did not induce genotoxicity neither skin sensitization. In vivo, SAPs were well-tolerated without any signs of acute systemic toxicity. Interestingly, SAPs were found to promote the migration of endothelial, macrophage, fibroblast, and neuronal-like cells in vitro, supporting a high potential for tissue regeneration. These findings contribute to the development and translation of SAP-based biomaterials for biomedical applications.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality

  • Albert, Marie-Christine
  • Uranga-Murillo, Iratxe
  • Arias, Maykel
  • De Miguel, Diego
  • Peña, Natacha
  • Montinaro, Antonella
  • Varanda, Ana Beatriz
  • Theobald, Sebastian J.
  • Areso, Itziar
  • Saggau, Julia
  • Koch, Manuel
  • Liccardi, Gianmaria
  • Peltzer, Nieves
  • Rybniker, Jan
  • Hurtado-Guerrero, Ramón
  • Merino, Pedro
  • Monzón, Marta
  • Badiola, Juan J.
  • Reindl-Schwaighofer, Roman
  • Sanz-Pamplona, Rebeca
  • Cebollada-Solanas, Alberto
  • Megyesfalvi, Zsolt
  • Dome, Balazs
  • Secrier, Maria
  • Hartmann, Boris
  • Bergmann, Michael
  • Pardo, Julián
  • Walczak, Henning
The dysregulated immune response and inflammation resulting in severe COVID-19 are still incompletely understood. Having recently determined that aberrant death-ligand-induced cell death can cause lethal inflammation, we hypothesized that this process might also cause or contribute to inflammatory disease and lung failure following SARS-CoV-2 infection. To test this hypothesis, we developed a novel mouse-adapted SARS-CoV-2 model (MA20) that recapitulates key pathological features of COVID-19. Concomitantly with occurrence of cell death and inflammation, FasL expression was significantly increased on inflammatory monocytic macrophages and NK cells in the lungs of MA20-infected mice. Importantly, therapeutic FasL inhibition markedly increased survival of both, young and old MA20-infected mice coincident with substantially reduced cell death and inflammation in their lungs. Intriguingly, FasL was also increased in the bronchoalveolar lavage fluid of critically-ill COVID-19 patients. Together, these results identify FasL as a crucial host factor driving the immuno-pathology that underlies COVID-19 severity and lethality, and imply that patients with severe COVID-19 may significantly benefit from therapeutic inhibition of FasL.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The importance of murine phospho-MLKL-S345 in situ detection for necroptosis assessment in vivo

  • Kelepouras, Konstantinos
  • Saggau, Julia
  • Varanda, Ana Beatriz
  • Zrilic, Matea
  • Kiefer, Christine
  • Rakhsh-Khorshid, Hassan
  • Lisewski, Ina
  • Uranga-Murillo, Iratxe
  • Arias, Maykel
  • Pardo, Julian
  • Tonnus, Wulf
  • Linkermann, Andreas
  • Annibaldi, Alessandro
  • Walczak, Henning
  • Liccardi, Gianmaria
Necroptosis is a caspase-independent modality of cell death implicated in many inflammatory pathologies. The execution of this pathway requires the formation of a cytosolic platform that comprises RIPK1 and RIPK3 which, in turn, mediates the phosphorylation of the pseudokinase MLKL (S345 in mouse). The activation of this executioner is followed by its oligomerisation and accumulation at the plasma-membrane where it leads to cell death via plasma-membrane destabilisation and consequent permeabilisation. While the biochemical and cellular characterisation of these events have been amply investigated, the study of necroptosis involvement in vivo in animal models is currently limited to the use of Mlkl−/− or Ripk3−/− mice. Yet, even in many of the models in which the involvement of necroptosis in disease aetiology has been genetically demonstrated, the fundamental in vivo characterisation regarding the question as to which tissue(s) and specific cell type(s) therein is/are affected by the pathogenic necroptotic death are missing. Here, we describe and validate an immunohistochemistry and immunofluorescence-based method to reliably detect the phosphorylation of mouse MLKL at serine 345 (pMLKL-S345). We first validate the method using tissues derived from mice in which Caspase-8 (Casp8) or FADD are specifically deleted from keratinocytes, or intestinal epithelial cells, respectively. We next demonstrate the presence of necroptotic activation in the lungs of SARS-CoV-infected mice and in the skin and spleen of mice bearing a Sharpin inactivating mutation. Finally, we exclude necroptosis occurrence in the intestines of mice subjected to TNF-induced septic shock. Importantly, by directly comparing the staining of pMLKL-345 with that of cleaved Caspase-3 staining in some of these models, we identify spatio-temporal and functional differences between necroptosis and apoptosis supporting a role of RIPK3 in inflammation independently of MLKL versus the role of RIPK3 in activation of necroptosis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

An agent-based method to estimate 3D cell migration trajectories from 2D measurements: Quantifying and comparing T vs CAR-T 3D cell migration

  • Camacho-Gómez, Daniel
  • Movilla, Nieves
  • Borau, Carlos
  • Martín, Alejandro
  • Oñate Salafranca, Carmen
  • Pardo, Julián
  • Gómez-Benito, María José
  • García-Aznar, José Manuel
Background and objective: Immune cell migration is one of the key features that enable immune cells to find invading pathogens, control tissue damage, and eliminate primary developing tumors. Chimeric antigen receptor (CAR) T-cell therapy is a novel strategy in the battle against various cancers. It has been successful in treating hematological tumors, yet it still faces many challenges in the case of solid tumors. In this work, we evaluate the three-dimensional (3D) migration capacity of T and CAR-T cells within dense collagen-based hydrogels. Quantifying three-dimensional (3D) cell migration requires microscopy techniques that may not be readily accessible. Thus, we introduce a straightforward mathematical model designed to infer 3D trajectories of cells from two-dimensional (2D) cell trajectories. Methods: We develop a 3D agent-based model (ABM) that simulates the temporal changes in the direction of migration with an inverse transform sampling method. Then, we propose an optimization procedure to accurately orient cell migration over time to reproduce cell migration from 2D experimental cell trajectories. With this model, we simulate cell migration assays of T and CAR-T cells in microfluidic devices conducted under hydrogels with different concentrations of type I collagen and validate our 3D cell migration predictions with light-sheet microscopy. Results: Our findings indicate that CAR-T cell migration is more sensitive to collagen concentration increases than T cells, resulting in a more pronounced reduction in their invasiveness. Moreover, our computational model reveals significant differences in 3D movement patterns between T and CAR-T cells. T cells exhibit migratory behavior in 3D whereas that CAR-T cells predominantly move within the plane, with limited movement in the direction. However, upon the introduction of a CXCL12 chemical gradient, CAR-T cells present migration patterns that closely resemble those of T cells. Conclusions: This framework demonstrates that 2D projections of 3D trajectories may not accurately represent real migration patterns. Moreover, it offers a tool to estimate 3D migration patterns from 2D experimental data, which can be easily obtained with automatic quantification algorithms. This approach helps reduce the need for sophisticated and expensive microscopy equipment required in laboratories, as well as the computational burden involved in producing and analyzing 3D experimental data.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors

  • Pesini, Cecilia
  • Artal, Laura
  • Paúl Bernal, Jorge
  • Sánchez Martinez, Diego
  • Pardo, Julián
  • Ramírez-Labrada, Ariel
Natural killer (NK) cells play a crucial role in antitumoral and antiviral responses. Yet, cancer cells can alter themselves or the microenvironment through the secretion of cytokines or other factors, hindering NK cell activation and promoting a less cytotoxic phenotype. These resistance mechanisms, often referred to as the “hallmarks of cancer” are significantly influenced by the activation of oncogenes, impacting most, if not all, of the described hallmarks. Along with oncogenes, other types of genes, the tumor suppressor genes are frequently mutated or modified during cancer. Traditionally, these genes have been associated with uncontrollable tumor growth and apoptosis resistance. Recent evidence suggests oncogenic mutations extend beyond modulating cell death/proliferation programs, influencing cancer immunosurveillance. While T cells have been more studied, the results obtained highlight NK cells as emerging key protagonists for enhancing tumor cell elimination by modulating oncogenic activity. A few recent studies highlight the crucial role of oncogenic mutations in NK cell-mediated cancer recognition, impacting angiogenesis, stress ligands, and signaling balance within the tumor microenvironment. This review will critically examine recent discoveries correlating oncogenic mutations to NK cell-mediated cancer immunosurveillance, a relatively underexplored area, particularly in the era dominated by immune checkpoint inhibitors and CAR-T cells. Building on these insights, we will explore opportunities to improve NK cell-based immunotherapies, which are increasingly recognized as promising alternatives for treating low-antigenic tumors, offering significant advantages in terms of safety and manufacturing suitability.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Risk factors and clinical impact of multi drug resistance in healthcare-associated bacteremic urinary tract infections: a post-hoc analysis of a multi center prospective cohort in Spain

  • Gómez Zorrilla, S.
  • Becerra Aparicio, F.
  • Sendra, E.
  • Zamorano, L.
  • Grau, I.
  • Pintado, V.
  • Padilla, B.
  • Benito, N.
  • Boix Palop, L
  • Fariñas, M.C.
  • Peñaranda, M.
  • Gamallo, M.R.
  • Martínez, J.A.
  • Morte Romea, E.
  • Del Pozo, J.L.
  • López Montesinos, I.
  • Durán Jordá, X.
  • Ponz, R.
  • Cotarelo, M.
  • Cantón, R.
  • Oliver, A.
  • Ruiz Garbajosa, P.
  • Horcajada, J.P.
Background: The global burden associated with antimicrobial resistance is of increasing concern. Aim: To evaluate risk factors associated with multidrug-resistant (MDR) infection and its clinical impact in a cohort of patients with healthcare-associated bacteraemic urinary tract infections (BUTIs). Methods: This was a prospective, multicentre, post-hoc analysis of patients with healthcare-associated-BUTI (ITUBRAS-2). The primary outcome was MDR profile. Secondary outcomes were clinical response (at 48–72 h and at hospital discharge) and length of hospital stay from onset of BUTI. Logistic regression was used to evaluate variables associated with MDR profile and clinical response. Length of hospital stay was evaluated using multivariate median regression. Findings: In all, 443 episodes were included, of which 271 (61.17%) were classified as expressing an MDR profile. In univariate analysis, MDR profile was associated with E. coli episodes (odds ratio (OR): 3.13; 95% confidence interval (CI): 2.11–4.69, P < 0.001) and the extensively drug-resistant (XDR) pattern with P. aeruginosa aetiology (7.84; 2.37–25.95; P = 0.001). MDR was independently associated with prior use of fluoroquinolones (adjusted OR: 2.43; 95% CI: 1.25–4.69), cephalosporins (2.14; 1.35–3.41), and imipenem or meropenem (2.08; 1.03–4.20) but not with prior ertapenem. In terms of outcomes, MDR profile was not associated with lower frequency of clinical cure, but was associated with longer hospital stay. Conclusion: MDR profile was independently associated with prior use of fluoroquinolones, cephalosporins, imipenem, and meropenem, but not with prior ertapenem. MDR-BUTI episodes were not associated with worse clinical cure, although they were independently associated with longer duration of hospital stay.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions: a prospective multicentre cohort (NO-BACT)

  • Girón Ortega, J.A.
  • Fernández Guerrero, R.
  • Montes de Oca Arjona, M.
  • Sánchez Galán, F.
  • Pellejero Sagastizábal, G.
  • Morte Romea, E.
  • De Cueto, M.
  • Beltrán García, M.
  • Palacios Baena, Z.
  • Jiménez Jorge, S.
  • Rodríguez Baño, J.
  • Retamar Gentil, P.
Objectives: To evaluate the appropriateness of antimicrobial treatment and the risk factors for mortality in patients with negative blood cultures (BC), in order to evaluate whether this population would be a suitable target for antimicrobial stewardship (AMS) interventions. Methods: A multicentre prospective cohort study of patients with negative BC in three Spanish hospitals between October 2018 and July 2019 was performed. The main endpoints were the appropriateness of antimicrobial treatment (evaluated by two investigators according to local guidelines) and 30-day mortality. Cox-regression was performed to estimate the association between variables and 30-day mortality. Results: Of 1011 patients in whom BC was obtained, these were negative in 803 (79%) and were included; 30-day mortality was 9% (70 patients); antibiotic treatment was considered inappropriate in 299 (40%) of 747 patients evaluated at day 2, and in 266 (46%) of 573 at day 5–7. The variables independently associated with increased risk of 30-day mortality were higher age (HR 1.05; 95% CI 1.03–1.07), neoplasia (HR 2.73; 95% CI 1.64–4.56), antibiotic treatment in the 48 h prior to BC extraction (HR 2.06; 95% CI 1.23–3.43) and insufficient antibiotic coverage at day 2 after BC obtainment (HR 2.35; 95% CI 1.39–4.00). Urinary, catheter and biliary sources of infection were associated with lower risk (HR 0.40; 95% CI 0.20–0.81). Conclusions: Antimicrobial treatment is frequently inappropriate among patients with negative BC; insufficient antibiotic coverage at day 2 was associated with mortality. These results suggest that patients with negative BC are a suitable population for AS interventions. Summary: Antimicrobial treatment in patients with negative blood culture was frequently inappropriate, and inappropriate coverage at day 2 was associated with increased risk of death. These data support the consideration of this population as a potential target for antimicrobial stewardship interventions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Preserved efficacy of lyophilized SARS-CoV-2 mRNA vaccine incorporating novel ionizable lipids after one year at 25 °C

  • Mata, Elena
  • Broset, Esther
  • Matute, Carlos
  • Stoian, Andrei
  • Adame, Susana
  • Alejo, Teresa
  • López, Alexandre
  • Andrés, Beatriz
  • Heredero, Juan
  • de Miguel, Diego
  • Giménez-Warren, Javier
  • Lampaya, Verónica
  • Casabona, Diego
  • Calvo, Alba
  • Quincoces, Gema
  • Peñuelas, Iván
  • Gamazo, Carlos
  • Uranga, Iratxe
  • Peña, Natacha
  • Arias, Maykel
  • Pardo, Julián
  • Moreno, Bernardino
  • Badiola, Juan
  • Martínez-Oliván, Juan
  • Pérez-Herrán, Esther
mRNA vaccines have shown great efficacy against SARS-CoV-2, yet challenges remain in optimizing vaccine components to achieve enhanced immune response and vaccine stability. In this study, we developed CPVax-CoV, a new lyophilized mRNA vaccine that features novel thiolactone-based ionizable lipids and newly designed untranslated regions (UTRs) for enhanced expression. Incorporation of these optimized components into our vaccine candidate CPVax-CoV significantly improved immune responses in mice compared to commercially available mRNA vaccines. Moreover, lyophilized CPVax-CoV has proven to be thermostable, maintaining its biological activity for up to one year at 4 °C and 25 °C after lyophilization, overcoming the cold-chain limitations of current mRNA vaccines. This vaccine demonstrates protective efficacy against ancestral SARS-CoV-2 and the Omicron XBB variant, offering a scalable solution for global distribution and pandemic preparedness. These findings underscore the potential of this platform for future next-generation mRNA vaccine development.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms

  • Pesini, Cecilia
  • Gil-Bellido, Mario
  • Millán, Lorena S.
  • Oñate, Carmen
  • Calvo-Pérez, Adanays
  • Santiago, Llipsy
  • Iglesias, Eldris
  • Bernal, Jorge Paúl
  • Araujo-Voces, Miguel
  • Paz Artigas, Laura
  • García-Martínez, Laura
  • Roig, Francisco J
  • Movilla Meno, Nieves
  • Garcia-Aznar, José Manuel
  • Menéndez-Jandula, Bárbara
  • Olave, María Teresa
  • Azaceta Reinares, Gemma
  • Garrote, Marta
  • Alvarez-Larrán, Alberto
  • Gálvez, Eva M
  • Sánchez Martínez, Diego
  • Arias, Maykel A
  • Pardo, Julian
  • Ramirez-Labrada, Ariel
Background The adoptive transfer of T cells engineered to express chimeric antigen receptors (CAR-T) has shown high efficacy and safety in treating various hematologic malignancies. However, many hematologic disorders, such as BCR::ABL1-negative myeloproliferative neoplasms (MPNs), lack effective treatment options. Some of these neoplasms are marked by a recurrent mutation that results in the expression of mutant calreticulin (mCALR), a neoantigen absent in healthy tissues, making it a highly specific and appealing target for CAR-T cell therapy. Methods Five distinct CARs were designed based on available monoclonal antibody sequences that target mCALR and were subsequently used to generate CAR-T cells. The most effective construct was selected through functional in vitro assays against mCALR-positive cell lines. Its efficacy was then evaluated in cell lines, patient-derived cells, and orthotopic xenograft models, assessing tumor burden, CAR-T cell infiltration, and animal survival. Bulk and single-cell RNA sequencing were performed on patient-derived cells and residual tumor cells from CART-treated mice, respectively, to investigate potential resistance mechanisms. The impact of the most relevant pathway alteration on CAR-T efficacy was also analyzed. Pharmacological rescue assays using targeted agents were then conducted. Results Among the five constructs, one demonstrated superior and specific cytotoxicity against mCALR-expressing cells, with no activity against mCALR-negative controls. This CAR-T cell also eliminated patient-derived MPN cells and controlled disease progression in xenograft models, which correlated with the persistence of CAR-T cells and tumor infiltration. Transcriptomic profiling of patient samples and residual tumor cells in spleens of treated mice revealed upregulation of anti-apoptotic proteins. Functional assays confirmed reduced CAR-T efficacy in Bcl-2 high cells, which was restored by co-treatment with venetoclax, indicating a viable combination approach to overcome resistance. Conclusions This study demonstrates, for the first time, the successful targeting of mCALR with CAR-T cells as a therapeutic strategy for MPNs. The chosen construct shows strong preclinical efficacy against established cell lines and patient-derived cells. Additionally, transcriptomic profiling uncovered apoptosis resistance mechanisms and supports a combination strategy with BH3 mimetics, such as venetoclax. These findings provide a compelling rationale for ongoing preclinical development and future clinical application of anti-mCALR CAR-T cells for the treatment of MPNs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Detection and genetic characterization of Crimean-Congo hemorrhagic fever virus in ticks from western Spain (2017, 2020-2024)

  • Sánchez-Mora, Patricia
  • Habela, Miguel A.
  • del Peso, Teresa
  • Grande Ávila, Ana Candela
  • García López, Ana María
  • Mata García Soldado, Jennifer
  • Tapia, María M.
  • Molero, Francisca
  • Herrero, Laura
  • Olmeda, A. Sonia
  • Valcárcel, Félix
  • Estrada-Peña, Agustín
  • Negredo, Anabel
  • Sánchez-Seco, María Paz
Introduction: Crimean-Congo hemorrhagic fever virus (CCHFV) was first detected in Spain in ticks collected from red deer in southwestern Cáceres. Since then, this region, established as endemic, has been the focus of several surveillance studies. However, updated data on viral circulation in this area remain limited. Materials and Methods: We conducted a retrospective surveillance study to assess the presence and genetic diversity of CCHFV in ticks collected in central and southern Cáceres over multiple years (2017 and 2020–2024). A total of 3,183 ticks, grouped into 1,569 pools, were collected from wild ungulates, livestock, domestic animals and vegetation, and analyzed by two PCR methods. Positive pools were characterized by Sanger sequencing. Results: CCHFV was exclusively detected in Hyalomma lusitanicum ticks, with an overall infection rate of 1.54% (95% CI: 1.14–2.03). Most positive pools originated from wild ungulates, particularly red deer. Genetic analysis revealed the circulation of two CCHFV genotypes, predominantly genotype III. Discussion: The detection of CCHFV in ticks collected over multiple years supports the sustained circulation of the virus in southwestern Cáceres. Our findings also reinforce the key role of H. lusitanicum as the main vector maintaining the virus in wild ungulates and underscore the genetic diversity of circulating strains and the importance of using multiple molecular methods. These results emphasize the need for continuous surveillance inendemic areas to monitor viral circulation and assess animal and public health risks.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Clonal dissemination and plasmid plasticity of KPC-3–producing Klebsiella pneumoniae ST512 during a hospital outbreak in Spain

  • Riesgo-Magaña, María
  • Moreno-Mingorance, Albert
  • Bueno, Jessica
  • Arnal, Sara
  • Alvarado, Elena
  • González-López, Juan José
  • Seral, Cristina
Purpose To describe the first outbreak of KPC-3-producing Klebsiella pneumoniae ST512 in Aragón, Spain, and characterize its clinical, microbiological, and genomic features, including plasmid dynamics, resistance mechanisms, and phylogenetic context. Methods Between July 2022 and July 2024, 130 KPC-3-producing K. pneumoniae isolates were recovered from 33 patients during an outbreak at a tertiary-care hospital in Zaragoza. Antimicrobial susceptibility testing and whole-genome sequencing were performed. Phylogenomic (SNP and cgMLST) and plasmid analyses defined clonal relatedness and plasmid structures. Comparative genomics with 985 international ST512/KPC-3 genomes determined phylogeographic relationships. Results Most cases (84.6%) were detected through active surveillance. All the isolates were resistant to β-lactams, ceftolozane/tazobactam, tobramycin and amikacin, while 64.4% remained susceptible to gentamicin. All the isolates were susceptible to cefiderocol, colistin, and tigecycline. One ceftazidime/avibactam-resistant isolate carrying blaKPC−70 emerged after prolonged therapy. Genomic analysis confirmed a clonal outbreak of Klebsiella pneumoniae ST512 (≤ 16 SNPs; ≤13 cgMLST allelic differences). Phylogenetic comparison showed that the isolates were genetically close to those from Italy and central Spain. All isolates carried blaKPC−3 within Tn4401b. Three blaKPC−3 plasmid structures were identified: an IncFII(K) plasmid (pHCUKPC3), a ColEST258 variant, and a novel cointegrate plasmid (pHCUKPC3co). The virulence-associated factors identified included yersiniabactin (ybt10/ICEKp4), KL107 capsular type, and O2afg O-antigen. Conclusion This study documents the wider dissemination of ST512/KPC-3 as a high-risk clone in Spain, characterized by persistence driven by clonal dissemination, selective pressure, and plasmid plasticity. Our findings highlight the need to integrate genomic and plasmidomic surveillance to anticipate resistance evolution and contain high-risk clones.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity

  • Marco, Sonia
  • Fernández, Myriam
  • Honorato, Beatriz
  • Juanarena, Nerea
  • Sainz, Cristina
  • Andueza, Ainhoa
  • Gould, David J.
  • Anderson, Seth
  • de Andrea, Carlos
  • Domínguez, Paulo Pérez
  • Wong, Paolo
  • Vásquez, Carlos
  • Narinda, Irene
  • Unzu, Carmen
  • Isola, Sergio
  • Tavira, Beatriz
  • Ariz, Mikel
  • Camps, Gracián
  • Sanmamed, Miguel F.
  • Pardo, Julián
  • Labiano, Sara
  • Alonso, Marta M.
  • Marco-Sanz, Javier
  • Guruceaga, Elizabeth
  • Collantes, María
  • Simón, Jon Ander
  • Peñuelas, Iván
  • Fernández-Irigoyen, Joaquín
  • Santamaría, Enrique
  • Prieto, Jesús
  • Dubrot, Juan
Radiotherapy (RT) can prime the immune system against cancer but often fails to generate effective antitumor responses due to concomitant induction of immunosuppressive factors. To overcome this limitation, we built upon the observation that RT enhances adeno-associated vectors (AAVs) tumor transduction through the epigenetic modification of vector episomes. We designed an AAV-based platform to deliver immunostimulatory cytokines through an interferon (IFN)-inducible promoter that allows for spatial control of transgene expression into irradiated tumors. As opposed to a constitutive system, local delivery of a vector encoding for inducible IL-12 (AAV-iIL12) achieves an efficient production of the cytokine without significant toxicity. Combination of RT and AAV-iIL12 generates a highly immunostimulatory tumor microenvironment (TME) leading to robust local and systemic antitumor responses in an IFNγ- and FAS-dependent manner, able to overcome common immune-evasion mechanisms. Our work shows that radiation coupled with AAV-based immune-gene delivery is an efficient and safe approach to treat cancer.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Circulating granzyme A is elevated within the dysregulated host response and associates with mortality in abdominal sepsis

  • Pellejero-Sagastizabal, Galadriel
  • Esteban, Patricia
  • Letona-Giménez, Santiago
  • Andrés-Tovar, Alejandro
  • Sierra, José Luis
  • Senan-Salinas, Ana
  • Galvez, Eva María
  • Pardo, Julián
  • Morte-Romea, Elena
  • Arias, Maykel
  • Paño-Pardo, José Ramón
Introduction Granzyme A (GzmA) has been identified as a key amplifier of sepsis-related inflammation in experimental models without contributing to pathogen clearance. However, its behavior and clinical relevance in human bacterial sepsis remain unknown. We aimed to characterize circulating GzmA in secondary peritonitis and explore its associations with clinical severity and all-cause mortality. Methods We conducted a single-center prospective cohort study of 42 adults with secondary peritonitis at Lozano Blesa Clinical Hospital (Zaragoza, Spain), with 31 healthy controls. Peripheral blood was obtained at baseline, 24 h, and 48 h. Serum GzmA concentration and activity, GzmB, cytokines, and endothelial and coagulation markers were measured. Analyses included comparisons across Sepsis-3 severity strata and exploratory prognostic models (logistic regression and receiver operating characteristic curves) evaluating associations between baseline biomarkers and mortality. Sensitivity analyses were performed after excluding patients meeting predefined immunosuppression criteria. Results At baseline, GzmA concentrations (2.3-fold, q-value = 5.41×10−12) and GzmA enzymatic activity (q-value = 6.75 × 10-³) were significantly higher in patients than controls, whereas GzmB did not differ (q-value = 0.332). Across baseline severity categories, VCAM-1 showed the clearest gradient (q-value = 0.017), while GzmA concentrations were numerically highest in septic shock (median 165.4 pg/mL). GzmA remained elevated through 48 h, and non-survivors had higher baseline levels than survivors. Each doubling of baseline GzmA was associated with higher overall in-hospital mortality (OR 2.52; 95% CI 1.11-5.75, p=0.028), with associations persisting after adjustment for age and comorbidity. Sensitivity analyses excluding immunosuppressed patients yielded a clearer association between GzmA and baseline severity, and confirmed its association with mortality. Discussion Circulating GzmA, but not GzmB, is markedly upregulated, remains elevated during early follow-up, and is preliminarily associated with mortality-related outcomes. These exploratory findings are consistent with experimental models and support further evaluations of extracellular GzmA to investigate its biological and potential translational relevance in sepsis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Antimicrobial therapy among hospitalized older adults with suspected infection and negative blood cultures

  • Pellejero-Sagastizabal, Galadriel
  • Morte-Romea, Elena
  • Girón Ortega, José Antonio
  • Paño-Pardo, José Ramón
  • Fernández Guerrero, Raquel
  • Guerrero, Francisca
  • Montes de Oca, Montserrat
  • Jiménez-Jorge, Silvia
  • Palacios-Baena, Zaira R.
  • Rodríguez-Baño, Jesús
  • Retamar-Gentil, Pilar
  • Montes de Oca Arjona, Montserrat
  • Galán Sánchez, Fátima
  • Rodríguez Mateos, María Eugenia
  • Girón-González, José Antonio
  • Martín Aspas, Andrés
  • Sánchez Tembleque, Claudio
  • Guerrero Sánchez, Francisca María
  • Morte-Romea, Elena
  • Pellejero-Sagastizabal, Galadriel
  • Luque Gómez, Pilar
  • Paño-Pardo, José Ramón
  • Sierra, José Luis
  • Letona Gimenez, Santiago
  • Palacián, Pilar
  • Rodriguez, Nora Mariela
  • Arenere Mendoza, Mercedes
  • Allende Bandrés, Maria Ángeles
  • Fresquet Molina, Raquel
  • Navarro Pardo, Irene
  • Girón Ortega, José Antonio
  • Fernández Guerero, Raquel
  • Retamar-Gentil, Pilar
  • Palacios-Baena, Zaira
  • de Cueto, Marina
  • Beltrán García, Margarita
  • Cantón Bulnes, María Luisa
  • Suarti, Lorenzo Roberto
  • Rodríguez-Baño, Jesús
Background Managing infections in older adults is challenging due to their unique characteristics, which often drives empirical antimicrobial use, increasing risks of adverse outcomes and antimicrobial resistance (AMR). Data on antimicrobial adequacy in older patients with suspected infection but negative blood cultures (BC) remain scarce, despite this being a common clinical scenario. Methods In this multicenter prospective cohort study (NO-BACT project) across three Spanish hospitals (2018–2019), we compared antimicrobial therapy adequacy between older adults (≥ 85 years) and younger patients with suspected infections and negative BC. Antimicrobial stewardship (AMS) experts evaluated treatment adequacy at days 2 and 5–7 using standardized guideline-based criteria. We assessed predictors of adequacy using logistic regression and examined clinical outcomes including 30-day mortality and length of hospital stay (LOS). Results Among 799 enrolled patients, 90 (11.3%) were older adults. While initial antimicrobial adequacy was comparable between groups at Day 2 (59.8% vs. 60.1%), older adults were significantly less likely to receive adequate treatment by Days 5–7 (adjusted OR 0.46, 95% CI 0.25–0.82, p = 0.009). The main drivers of inadequacy were excess antimicrobial spectrum (84.2%) and inappropriate route of administration (48.7%). Older adults demonstrated higher 30-day mortality (16.7% vs. 7.8%; p = 0.009) despite shorter LOS (8 vs. 10 days, p = 0.006), though treatment adequacy was not associated with mortality. Conclusions In older patients with negative BC, antimicrobial therapy shows high rates of inadequacy that worsen over time, primarily due to delayed de-escalation and prolonged intravenous therapy. These findings identify a clear target for AMS interventions focusing on timely treatment optimization.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Unexpected uterine microhabitat of Schistosoma infection: a migrant case of female genital schistosomiasis in Europe

  • Beltrán-Rosel, Antonio
  • Ligero-López, Jorge
  • Ornat-Clemente, Lia
  • Mejía-Urbáez, Elaine
  • Tébar-Fuentes, Reyes
  • Goñi, Pilar
  • López-Alonso, Beatriz
  • De Elías-Escribano, Alejandra
  • Artigas, Patricio
  • Fantozzi, María Cecila
  • Bargues, María Dolores
Background Female genital schistosomiasis (FGS) is an underrecognized cause of infertility and may remain undiagnosed in non-endemic settings because of nonspecific symptoms and limited sensitivity of routine diagnostic tests. Case presentation We report the case of a 30-year-old woman from Côte d’Ivoire who had lived in Mali before migrating to Spain and then presented with primary infertility. Initial fertility workup revealed a large intramural–submucosal leiomyoma. Following myomectomy, histopathological examination unexpectedly identified Schistosoma eggs associated with granulomatous inflammation in the myometrial specimen. Initial Schistosoma serology and urine microscopy were negative. Hysterosalpingography later demonstrated right hydrosalpinx, prompting reconsideration of schistosomiasis. Repeated urine samples collected after endometrial biopsy revealed Schistosoma haematobium-like eggs, confirming the diagnosis. Retrospective review showed previous eosinophilia despite the absence of urinary symptoms or hematuria. The patient was treated with praziquantel, and follow-up samples were negative. Conclusions This case highlights FGS as a potentially reversible cause of infertility in migrant women from endemic regions. It also underscores the diagnostic limitations of serology and urine microscopy and the importance of histopathological examination in establishing the diagnosis.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound

  • Resa-Infante, Patricia
  • Piñol, Patricia
  • Laguía, Fernando
  • Campos-Gonzalez, Gerard
  • Cobos, Àlex
  • Urrea, Victor
  • Garcia-Guerrero, Maria del Carmen
  • Rosales-Salgado, Yaiza
  • Cid, Marina
  • Díaz-Pedroza, Jorge
  • Shultz, Leonard D
  • Yin, Voot
  • Brehm, Michael A.
  • Soper, Brian
  • Salgado, María
  • Martinez-Picado, Javier
Despite advances in antiretroviral therapy (ART), HIV-1 cure efforts remain hindered by viral persistence in long-lived myeloid cells and immune-privileged tissues that are poorly accessible and therefore unlikely to be assessed in human clinical trials. Consequently, robust research platforms, such as immune-cell humanized mice, are needed to bridge preclinical and clinical HIV research. However, previously described humanized mouse models often show incomplete hematopoietic development, particularly showing low levels of NK or myeloid cells. Herein, we evaluate a humanized FLT3 mouse model that develops NK cells, myeloid progenitors, monocytes, and both conventional (cDCs) and plasmacytoid dendritic cells (pDCs), and assessed its capacity to support HIV-1 infection, persistence, and viral rebound. Human cord blood derived CD34+ hematopoietic stem cells (HSC) were engrafted in FLT3 (Hu-FLT3) and NSG (Hu-NSG) mouse strains for comparison. While Hu-NSG and Hu-FLT3 mice showed comparable human lymphocyte levels, the proportion of myeloid-enriched populations, including monocytes, pDCs and cDCs, was three-fold higher in Hu-FLT3 mice (16.2%) than in Hu-NSG mice (5.6%), and the proportion of NK cells was six-fold higher (12.8% vs. 1.9%). Both strains supported HIV-1 infection, maintained viral replication for 17 weeks in untreated animals, and had detectable proviral DNA in peripheral blood, bone marrow and spleen. Oral ART reduced plasma HIV-1 RNA to undetectable levels within four weeks in both strains. After treatment discontinuation, viral rebound occurred within three weeks and approached pre-ART levels, consistent with rebound kinetics observed after treatment interruption in people living with HIV (PLWH). Human immune cells and HIV-1 RNA were more abundant in tissues from Hu-FLT3 mice than in Hu-NSG mice. This study establishes Hu‑FLT3 mice as a novel, robust and accessible in vivo platform to investigate potential HIV cure and persistence‑targeting interventions with translational relevance to human therapeutic development thanks to the improved and more complete human immune repertoire in Hu-FLT3., The authors’ laboratories were supported by funding from the Spanish Ministry of Science and Innovation (grants PID2022-139271OB-I00 and CB21/13/00063, Spain), Generalitat de Catalunya (CERCA program and 2021-SGR-00452) NIH/NIAID (1UM1AI164561-01 and 1P01AI178376-01, United States of America), and Grifols (Spain). FL and GC-G were supported by PhD fellowships (PRE2020-095004 and PRE2021-100501, respectively) from Spanish Ministry of Science and Innovation. MS was supported by the Miguel Servet Fellowship Program (CP22/00038) and I+D+I Grant (PID2023-147320OB-I00) from the Spanish Ministry of Science and Innovation. MAB and LDS were supported by funding from NIH (R24OD036199) and by the Barbara D. Cammett Breakthrough T1D Center of Excellence in New England of the Breakthrough T1D Foundation (4-COE-2025-1751-A-N)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Prevalence and morbidity of urogenital schistosomiasis among pre-school age children in Cubal, Angola

  • Sánchez-Marqués, Raquel
  • Bocanegra García, Maria Cristina
  • Nindia, Arlette
  • Pintar, Zeferino
  • Aixut, Sandra
  • Martínez-Campreciós, Joan
  • Sulleiro, Elena
  • Espiau, María
  • Molina Romero, Israel
  • Salvador Velez, Fernando
Morbidity; Urine; Schistosomiasis, Morbilidad; Orina; Esquistosomiasis, Morbilitat; Orina; Esquistosomiasi, Background: Schistosomiasis is one of the most important neglected tropical diseases, with a great impact on public health and more than 200,000 deaths annually. Schistosoma haematobium causes urinary tract (UT) morbidity. Since schistosomiasis morbidity control programs focus on children older than 5 years, pre-school age children (PSAC) morbidity is not well known. Methods: We conducted a cross-sectional study in Cubal (Angola) among 245 PSAC with the objective of evaluating the prevalence of S. haematobium infection, the intensity of infection, and associated morbidity. For this purpose, urine filtration test followed by microscopic visualization and ultrasound examinations were performed. Results: The estimated overall prevalence of urogenital schistosomiasis was 30.2% (CI 95%; 24.5-35.9), with 20.3% (CI 95%; 15.3-25.3) of the samples analysed showing a high intensity of infection. A total of 54.5% (CI 95%; 47.6-61.8) of infected children presented UT lesions, showing a significant association between schistosomiasis infection and UT morbidity (p-value < 0.001). Bladder wall thickening was the most common lesion, being present in 100% of abnormal ultrasounds. We found that anaemia and severe malnutrition were not significantly associated with the development of UT lesions. Conclusions: S. haematobium infection in PSAC causes great UT detectable morbidities. Therefore, there is an evident need of including them in mass drug administration (MDA) campaigns and consequently the development of an adapted praziquantel treatment dosage for children under 2 years of age., This research was supported by the Red de Investigación de Centros de Enfermedades Tropicales–RICET (Grant No. RD16/0027/0023 and RD16/0027/0003) of the PN de I+D+I, ISCIII-Subdirección General de Redes y Centros de Investigación Cooperativa RETICS), Spanish Ministry of Health and Consumption; by CIBER de Enfermedades Infecciosas (Grant No. CB21/13/00056 and CB21/13/00029), ISCIII, Spanish Ministry of Science and Education; and by the PROMETEO Program, Programa of Ayudas para Grupos de Investigación de Excelencia, Generalitat Valenciana (Grant No. 2021/004).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 in Captive Nonhuman Primates, Spain, 2020–2023

  • Cano-Terriza, David
  • Beato-Benítez, Adrián
  • Fernández-Bastit, Leira
  • Segalés, Joaquim
  • Vergara-Alert, Júlia
  • Martínez-Nevado, Eva
  • Carretero, Andrea
  • Crailsheim, Dietmar
  • Soriano, Pilar
  • Planas, Javier
  • Torro, Mario
  • García-Bocanegra, Ignacio
We conducted a serologic and molecular study to assess exposure of captive nonhuman primates (NHPs) to SARS-CoV-2 in Spain during the 2020–2023 COVID-19 pandemic. We found limited exposure of NHPs to SARS-CoV-2. Biosafety measures must be strictly maintained to avoid SARS-CoV-2 reverse-zoonotic transmission in the human–NHP interface., We thank Bioparc Fuengirola, Bioparc Valencia, Centro de Conservación Zoo Córdoba, Faunia, Marcelle Naturaleza, MundoMar Benidorm, Parque de la Naturaleza de Cabárceno, Selwo Aventura, Terra Natura Murcia, Zoo de Santillana del Mar, and Centro de Conservación de la Biodiversidad Zoobotánico Jerez-Alberto Durán for providing the valuable samples. This research was partially supported by the Innovation and Transfer Plan of the University of Cordoba and CIBER, Consorcio Centro de Investigación Biomédica en Red (CB2021/13/00083), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea–NextGenerationEU. A.B.-B. is a PhD. candidate supported by the Andalusian System of Knowledge., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Schistosoma haematobium infection and morbidity risk factors for pre-school age children in western Angola: A knowledge, attitudes and practices survey

  • Bocanegra, Cristina
  • Nindia, Arlette
  • Pintar, Zeferino
  • Martínez-Campreciós, Joan
  • Aixut, Sandra
  • Molina Romero, Israel
  • Sánchez-Marqués, Raquel
  • Salvador Velez, Fernando
Schistosomiasis; Medical risk factors; Morbidity, Esquistosomiasi; Factors de risc mèdic; Morbilitat, Esquistosomiasis; Factores de riesgo médico; Morbilidad, Background Urogenital schistosomiasis is one of the most prevalent parasitic diseases in sub-Saharan Africa. It is a poverty-related disease conditioned by behavioural practices. Methods Our objective is to evaluate the awareness, mindset and habits about urogenital schistosomiasis in the community of Cubal (Angola), as well as its association with infection and urinary tract morbidity in pre-school age children. A cross-sectional study of knowledge, attitudes and practices at home was conducted between February and May 2022 with 250 participants. Results Overall, 93.6% of those surveyed had some prior knowledge about schistosomiasis and, among all the symptoms associated with this disease, blood in the urine was the best known (54.4%). Nevertheless, 57.6% obtained a medium knowledge score. Regarding attitude, the majority of respondents had a high attitude score (79.2%) with 96.0% willing to participate in mass drug administration campaigns. Laundry in the river was the most common risk practice (61.2%) and 55.2% out of the total were classified with a low practice score. Conclusion Low knowledge about symptoms and transmission by caregivers was the outstanding risk factor for infection in pre-school age children (OR = 16.93, 95%CI: 3.93–72.82), and lack of knowledge that avoiding entering the river prevents schistosomiasis was the main risk factor for morbidity in PSAC (OR = 8.14, 95%CI: 1.14–58.25)., This research was supported by the Red de Investigación de Centros de Enfermedades Tropicales – RICET of the PN de I+D+I, ISCIII-Subdirección General de Redes y Centros de Investigación Cooperativa RETICS), Ministry of Health and Consumption, Madrid; by CIBER de Enfermedades Infecciosas (Projects CB21/13/00056 and CB21/13/00029), ISCIII, Ministry of Science and Education, Madrid; by Project No. 2021/004 of the PROMETEO Program, Programa de Ayudas para Grupos de Investigación de Excelencia, Generalitat Valenciana, Valencia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

No innocent bystanders: pertussis vaccination and evolutionary parallelisms between Bordetella parapertussis and Bordetella pertussis

  • Bouchez, Valérie
  • Landier, Annie
  • Armatys, Nathalie
  • Guillot, Sophie
  • Moreno-Mingorance, Albert
  • Mir-Cros, Alba
  • Martin Gomez, M. Teresa
  • González-López, Juan José
Bordetella parapertussis; Phylogenetic diversity; Vaccine driven evolution, Bordetella parapertussis; Diversidad filogenética; Evolución impulsada por vacunas, Bordetella parapertussis; Diversitat filogenètica; Evolució impulsada per vacunes, Pathogens adapting to the human host and to vaccination-induced immunity may follow parallel evolutionary paths. Bordetella parapertussis (Bpp) contributes significantly to the burden of whooping cough (pertussis) and shares vaccine antigens with Bordetella pertussis (Bp); both pathogens are phylogenetically related and ecological competitors. Bp vaccine antigen-coding genes have accumulated variation, including pertactin (PRN) disruptions, after the introduction of acellular vaccines in the 1990s. We aimed to evaluate evolutionary parallelisms in Bpp, even though pertussis vaccines were designed against Bp. We sequenced 242 Bpp isolates collected in France, the USA and Spain between 1937 and 2019, spanning pre-vaccine and two vaccines eras. We investigated the temporal evolution of Bpp sublineages using a Bayesian approach based on whole-genome SNPs and performed comparative genomic analyses focusing on antigen and virulence gene loci. The most recent common ancestor of all sequenced Bpp isolates was estimated around the year 1877, making it one of the youngest human pathogens, and the Bpp evolutionary rate we estimated (2.12×10−7 substitutions per site per year) was remarkably similar to the one previously reported for Bp (2.24×10−7). PRN antigen deficiency in Bpp was driven by 18 disruptive mutations, including deletion prn:ΔG-1895 estimated to have occurred around 1998 and observed in 73.8 % (149/202) of post-2007 Bpp isolates. In addition, we detected two early (year ~1900) mutations in the bvgA-fhaB intergenic region, which controls multiple virulence factors including the filamentous haemagglutinin antigen. Gene clusters for pertussis toxin and fimbriae showed a surprising lack of gene decay. Our findings suggest early adaptation of Bpp to humans through modulation of the bvgAS regulon, and a rapid adaptation through the loss of PRN expression, representing a late evolutionary parallelism concomitant with acellular vaccination against whooping cough., The French National Reference Center for Whooping Cough and Other Bordetella Infections receives support from Institut Pasteur and Public Health France (Santé publique France, Saint Maurice, France). This work was supported financially by the French Government’s Investissement d’Avenir grants Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID) and INCEPTION (ANR-16-CONV-0005) and by the Spanish ‘Ministerio de Economía y Competitividad’ and ‘Instituto de Salud Carlos III’ [grant number FIS PI18/00703], and by the Centro de Investigación Biomédica en Red (CIBER de Enfermedades Infecciosas [grant number CB21/13/00054]). This work was also supported by the CDC’s Advanced Molecular Detection (AMD) programme.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Assessment of SARS-CoV-2 exposure in exotic pets in Spain

  • Cano-Terriza, David
  • Fernández-Bastit, Leira
  • Vergara-Alert, Júlia
  • Váquez-Calero, Daniel B.
  • Castro-Scholten, Sabrina
  • Caballero-Gomez, Javier
  • García-Bocanegra, Ignacio
  • Segalés, Joaquim
Evidence of SARS-CoV-2 infections in different animal species raises concerns about the potential for animal reservoirs and transmission to humans. Here, we evaluate the exposure of exotic pet species to this virus throughout the early years of the pandemic (2020 – 2022) in southern Spain. A total of 180 exotic pets (126 domestic rabbits, 31 ferrets, and 23 rodents) were analyzed for antibodies against SARS-CoV-2 using two different ELISAs. ELISA-positive sera were subsequently tested for specific neutralizing antibodies (nAbs) using the virus neutralization test (VNT). Only one brown rat (Rattus norvegicus), representing 0.6 % of the total, tested positive by ELISA, yet showed negative result for SARS-CoV-2 nAbs by VNT. Our results suggest a very limited risk of SARS-CoV-2 transmission among humans and sympatric exotic pet species in the study region. However, the virus's potential for interspecies transmission emphasizes the need for ongoing surveillance, especially in settings with frequent human-animal interactions, to avoid potential virus evolution, the emergence of new animal reservoirs, and spillover events., This research was partially supported by the Innovation and Transfer Plan of the University of Cordoba and CIBER -Consorcio Centro de Investigación Biomédica en Red- (CB2021/13/00083), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea–NextGenerationEU. Leira Fernández-Bastit was supported by the crowdfunding initiative #Yomecorono, available online at: https://www.yomecorono.com (accessed on 9 December 2024). Sabrina Castro-Scholten holds a PhD contract supported by the Spanish Ministry of Universities (FPU19/06026)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

  • Sola-Campoy, Pedro Juan
  • Delgado-Valverde, Mercedes
  • Cano, María E.
  • Gijón, Desirèe
  • Larrosa Escartin, María Nieves
  • Gonzalez Lopez, Juan Jose
  • Cañada-Garcia, Javier E.
  • Moure Garcia, Zaira
Carbapenemases; High-risk clones; Whole genome sequencing, Carbapenemasas; Clones de alto riesgo; Secuenciación del genoma completo, Carbapenemases; Clons d'alt risc; Seqüenciació del genoma sencer, Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were blaOXA–48 (263/377), blaKPC–3 (62/377), blaVIM–1 (28/377), and blaNDM–1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3., This research was supported by grants from the Instituto de Salud Carlos III (numbers PI18CIII/00030 and PI21CIII/00039). It was also supported by Plan Nacional de I + D + i 2013–2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (grants RD16CIII/0004/0002, RD16/0016/0001, RD16/0016/0003, RD16/0016/0004, RD16/0016/0006, RD16/0016/0007, RD16/0016/0008, RD16/0016/0010, and RD16/0016/0011). Cofinanced by the European Development Regional Fund “A way to achieve Europe,” Operative Program Intelligent Growth 2014–2020. CIBER – Consorcio Centro de Investigación Biomédica en Red (CB21/13/00095, CB21/13/00012, CB21/13/00049, CB21/13/00054, CB21/13/00055, CB21/13/00068, CB21/13/00081, CB21/13/00084, and CB21/13/00099) (CIBERINFEC) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU also supported this work.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Increasing trend of antimicrobial resistance in Shigella associated with MSM transmission in Barcelona, 2020–21: outbreak of XRD Shigella sonnei and dissemination of ESBL-producing Shigella flexneri

  • Moreno-Mingorance, Albert
  • Mir Cros, Alba
  • Goterris Bonet, Lidia
  • Rodríguez Garrido, Virginia
  • Sulleiro, Elena
  • Barberà Gracia, Mª Jesús
  • Descalzo Jorro, Vicente
  • Bravo, Albert
  • Roca, Josep
  • González-López, Juan José
  • Pumarola Suñe, Tomàs
  • VIÑADO, BELEN
  • Larrosa, María Nieves
  • Hoyos Mallecot, Yannick
Antimicrobial resistance; Shigella sonnei; Sexually transmitted infection, Resistencia antimicrobiana; Shigella sonnei; Infección de transmisión sexual, Resistència antimicrobiana; Shigella sonnei; Infecció de transmissió sexual, Background Several countries have recently reported the detection of ESBL-producing Shigella sonnei associated with transmission among MSM. In a previous study by our group, 2.8% of Shigella spp. obtained from MSM in Barcelona between 2015 and 2019 were ESBL producers. Objectives To describe and characterize the emerging ESBL-producing Shigella spp. associated with sexual transmission among MSM detected from 2020 to 2021 in Barcelona, elucidating their connectivity with contemporaneous ESBL-producing Shigella spp. from other countries. Results From 2020 to 2021, we identified that among MSM, 68% of S. sonnei were XDR harbouring blaCTX-M-27 and 14% of Shigella flexneri were MDR harbouring blaCTX-M-27. WGS analysis showed that the ESBL-producing S. sonnei were part of a monophyletic cluster, which included isolates responsible for the prolonged outbreak occurring in the UK. Our data also reveal the first emergence and clonal dissemination of ESBL-producing and fluoroquinolone-resistant S. flexneri 2a among MSM. Conclusions We report an increasing trend of antimicrobial resistance in Shigella spp. among MSM in Barcelona since 2021, mainly as a consequence of the dissemination of XDR ESBL-producing S. sonnei, previously reported in the UK. These results highlight the importance of international collaborative surveillance of MDR/XDR S. sonnei and S. flexneri for rapid identification of their emergence and the prevention of the transmission of these pathogens., This work was partially supported by the ‘Ministerio de Economía y Competitividad’, ‘Instituto de Salud Carlos III’, and co-financed by the European Regional Development Fund (ERDF) ‘A Way to Achieve Europe’ (Spanish Network for Research in Infectious Diseases, grant number RD16/0016/0003) and by the Centro de Investigación Biomédica en Red (CIBER de Enfermedades Infecciosas, grant no. CB21/13/00054). A.M.M. is supported by a grant from the ‘Fondo de Investigación Sanitaria’ (Contratos Predoctorales de Formación en Investigación, grant number FI19/00315).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Survey of severe acute respiratory syndrome coronavirus 2 in captive and free-ranging wildlife from Spain

  • Serra Gironella, Joan
  • Cano-Terriza, David
  • Caballero-Gómez, Javier
  • Beato-Benítez, Adrián
  • Fernández, Antonio
  • García-Párraga, Daniel
  • Domingo, Mariano
  • Sierra, Cecilia
  • Canales, Rocío
  • Borragan, Santiago
  • de la Riva‑Fraga, Manuel
  • Molina‑López, Rafael
  • Cabezón, Óscar
  • Puig‑Ribas, Maria
  • Espunyes, Johan
  • Vázquez‑Calero, Daniel B.
  • Vergara-Alert, Júlia
  • García‑Bocanegra, Ignacio
  • Segalés, Joaquim
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), considered a zoonotic agent of wildlife origin, can infect various animal species, including wildlife in free-range and captive environments. Detecting susceptible species and potential reservoirs is crucial for preventing the transmission, spread, genetic evolution, and further emergence of viral variants that are major threats to global health. This study aimed to detect exposure or acute infection by SARS-CoV-2 in 420 animals from 40 different wildlife species, including terrestrial and aquatic mammals, from different regions of Spain during the 2020-2023 coronavirus disease 19 (COVID-19) pandemic. In total, 8/137 animals were positive for SARS-CoV-2 antibodies against the receptor binding domain and/or viral nucleoprotein according to independent ELISAs. However, only one ELISA-positive sample of a captive bottlenose dolphin (Tursiops truncatus) tested positive for SARS-CoV-2 neutralizing antibodies with a low titre (SNT50 38.15) according to a virus neutralization test. Cetaceans are expected to have a high risk of infection with SARS-CoV-2 according to early predictive studies due to the similarity of their angiotensin converting enzyme 2 cell receptor to that of humans. Moreover, of 283 animals analysed for SARS-CoV-2 RNA using RT-qPCR, none tested positive. Our results reinforce the importance of considering cetaceans at risk for SARS-CoV-2 infection and support taking preventive biosecurity measures when interacting with them, especially in the presence of individuals with suspected or confirmed COVID-19. Although most animals in this study tested negative for acute infection or viral exposure, ongoing surveillance of wildlife species and potentially susceptible animals is important to prevent future spillover events and detect potential novel reservoirs., This research was partially supported by the Innovation and Transfer Plan of the University of Cordoba (UCO-SOCIAL-INNOVA) and CIBER—Consorcio Centro de Investigación Biomédica en Red—(CB2021/13/00083), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea–Next Generation EU. L. Fernández-Bastit was supported by the crowdfunding initiative # Yomecorono [57]. A. Beato-Benítez holds a PhD contract supported by the Andalusian System of Knowledge. M. P. Ribas was funded through the 2021 FI Scholarship, Departament de Recerca i Universitats, Generalitat de Catalunya, Spain (FI_B 00171)., info:eu-repo/semantics/publishedVersion
Docta Complutense
Publicación Artículo científico (JournalArticle)

Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era

  • Lara Aguilar, Violeta
  • Llamas Adán, Manuel
  • Brochado Kith, Óscar
  • Crespo Bermejo, Celia
  • Grande García, Sergio
  • Arca Lafuente, Sonia
  • De los Santos, Ignacio
  • Prado, Carmen
  • Alía, Mario
  • Sainz Pinós, Coral
  • Fernández Rodríguez, Amanda
  • Martín Carbonero, Luz
  • Madrid González, Ricardo
  • Briz, Verónica
Background Around 10% of people with HIV (PWH) exhibit a low-level viremia (LLV) under antiretroviral therapy (ART). However, its origin and clinical significance are largely unknown, particularly at viremias between 50 and 200 copies/mL and under modern ART based on integrase strand transfer inhibitors (INSTIs). Our aim was to characterize their poor immune response against HIV in comparison to individuals with suppressed viremia (SV) and non-HIV controls (NHC). Methods Transversal observational study in 81 matched participants: 27 PWH with LLV, 27 PWH with SV, and 27 NHC. Activation (CD25, HLA-DR, and CD38) and senescence [CD57, PD1, and HAVCR2 (TIM3)] were characterized in peripheral T-cell subsets by spectral flow cytometry. 45 soluble biomarkers of systemic inflammation were evaluated by immunoassays. Differences in cell frequencies and plasma biomarkers among groups were evaluated by a generalized additive model for location, scale, and shape (GAMLSS) and generalized linear model (GLM) respectively, adjusted by age, sex at birth, and ART regimen.</jats:p> Results The median age was 53 years and 77.8% were male. Compared to NHC, PWH showed a lower CD4+/CD8+ ratio and increased activation, senescence, and inflammation, highlighting IL-13 in LLV. In addition, LLV showed a downtrend in the frequency of CD8+ naive and effector memory (EM) type 1 compared to SV, along with higher activation and senescence in CD4+ and CD8+ EM and terminally differentiated effector memory RA+ (TEMRA) subpopulations. No significant differences in systemic inflammation were observed between PWH groups. Conclusion LLV between 50 and 200 copies/mL leads to reduced cytotoxic activity and T-cell dysfunction that could affect cytokine production, being unable to control and eliminate infected cells. The increase in senescence markers suggests a progressive loss of immunological memory and a reduction in the proliferative capacity of immune cells. This accelerated immune aging could lead to an increased risk of developing future comorbidities. These findings strongly advocate for heightened surveillance of these PWH to promptly identify potential future complications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of COVID-19 Lockdown in Eating Disorders, A Multicentre Collaborative International Study

  • Baenas Soto, Isabel Maria|||0000-0001-7415-0616
  • Etxandi Santolaya, Mikel|||0000-0002-5924-8495
  • Munguía Godínez, Jazmín Lucero|||0000-0002-9751-810X
  • Granero, Roser|||0000-0001-6308-3198
  • Mestre-Bach, Gemma|||0000-0001-5345-0484
  • Sánchez Díaz, Isabel María|||0000-0001-5874-8204
  • Ortega, Emilio|||0000-0002-2217-8905
  • Andreu, Alba|||0000-0001-9854-1531
  • Moize, Violeta L.
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Dieguez, Carlos|||0000-0002-0919-4337
  • Frühbeck, Gema|||0000-0002-8305-7154
  • Le Grange, Daniel|||0000-0001-7293-9496
  • Tchanturia, Kate|||0000-0001-8988-3265
  • Karwautz, Andreas|||0000-0001-9053-998X
  • Zeiler, Michael|||0000-0002-7087-6134
  • Imgart, Hartmut
  • Zanko, Annika
  • Favaro, Angela|||0000-0002-6540-5194
  • Claes, Laurence|||0000-0002-2287-3158
  • Shekriladze, Ia|||0000-0002-2787-0503
  • Serrano-Troncoso, Eduardo|||0000-0002-4935-7348
  • Cecilia-Costa, Raquel
  • Rangil, Teresa
  • Loran-Meler, Maria Eulalia
  • Soriano Pacheco, José|||0000-0002-5995-6977
  • Carceller-Sindreu, Mar|||0000-0001-7504-3935
  • Navarrete, Rosa
  • Lozano, Meritxell
  • Linares, Raquel
  • Gudiol, Carlota|||0000-0003-3095-4422
  • Carratalà, Jordi|||0000-0003-3209-2563
  • Plana, Maria T.
  • Graell, Montserrat
  • González-Parra, David
  • Gómez del Barrio, Andres|||0000-0002-0843-2575
  • Sepúlveda, Ana R.|||0000-0002-6041-2889
  • Sánchez González, Jéssica|||0000-0002-9327-0100
  • Machado, Paulo P. P.|||0000-0003-4277-9203
  • Håkansson, Anders|||0000-0002-5800-8975
  • Túry, Ferenc|||0000-0002-7283-5088
  • Pászthy, Bea|||0000-0002-8009-3811
  • Stein, Daniel
  • Papezová, Hana|||0000-0001-8145-3295
  • Gricova, Jana
  • Bax, Brigita
  • Borisenkov, Mikhail F.|||0000-0002-4310-2010
  • Popov, Sergey V.|||0000-0003-1763-8898
  • Gubin, Denis G.
  • Petrov, Ivan M.|||0000-0003-0823-3434
  • Isakova, Dilara
  • Mustafina, Svetlana V.|||0000-0003-4716-876X
  • Kim, Youl-Ri|||0000-0002-5538-7180
  • Nakazato, Michiko|||0000-0002-4025-7594
  • Godart, Nathalie|||0000-0002-7233-6991
  • van Voren, Robert|||0000-0001-9010-3115
  • Ilnytska, Tetiana|||0000-0003-1734-1568
  • Chen, Jue
  • Rowlands, Katie
  • Voderholzer, Ulrich|||0000-0003-0261-3145
  • Monteleone, Alessio M.
  • Treasure, Janet|||0000-0003-0871-4596
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Background. The COVID-19 lockdown has had a significant impact on mental health. Patients with eating disorders (ED) have been particularly vulnerable. Aims. (1) To explore changes in eating-related symptoms and general psychopathology during lockdown in patients with an ED from various European and Asian countries; and (2) to assess differences related to diagnostic ED subtypes, age, and geography. Methods. The sample comprised 829 participants, diagnosed with an ED according to DSM-5 criteria from specialized ED units in Europe and Asia. Participants were assessed using the COVID-19 Isolation Scale (CIES). Results. Patients with binge eating disorder (BED) experienced the highest impact on weight and ED symptoms in comparison with other ED subtypes during lockdown, whereas individuals with other specified feeding and eating disorders (OFSED) had greater deterioration in general psychological functioning than subjects with other ED subtypes. Finally, Asian and younger individuals appeared to be more resilient. Conclusions. The psychopathological changes in ED patients during the COVID-19 lockdown varied by cultural context and individual variation in age and ED diagnosis. Clinical services may need to target preventive measures and adapt therapeutic approaches for the most vulnerable patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

  • Reverté Calvet, Laia|||0000-0003-4690-2387
  • Yeregui, Elena|||0000-0003-2994-4219
  • Olona, Montserrat|||0000-0001-5303-9361
  • Gutiérrez-Valencia, Alicia|||0000-0003-3445-1574
  • Buzón, Maria José|||0000-0003-4427-9413
  • Martí, Anna
  • Gómez-Bertomeu, Frederic
  • Auguet, Teresa
  • López Cortés, Luis Fernando|||0000-0002-3804-3458
  • Burgos, Joaquín|||0000-0001-8445-3047
  • Benavent-Bofill, Clara
  • Boqué, Carme
  • García-Pardo, Graciano|||0000-0003-0274-6001
  • Ruiz-Mateos, Ezequiel|||0000-0001-6747-7813
  • Mestre, Maria Teresa
  • Vidal, Francesc|||0000-0002-6692-6186
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Rull, Anna|||0000-0002-8907-7754
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

  • Cañada-García, Javier E.
  • Moure García, Zaira
  • Sola-Campoy, Pedro J.
  • Delgado-Valverde, Mercedes
  • Cano, María E.
  • Gijón, Desirèe
  • González, Mónica
  • Gracia-Ahufinger, Irene
  • Larrosa, María Nieves|||0000-0001-8808-0233
  • Mulet, Xavier
  • Pitart, Cristina|||0000-0002-3083-7915
  • Rivera, Alba|||0000-0002-9709-6162
  • Bou, German|||0000-0001-8837-0062
  • Calvo, Jorge
  • Cantón, Rafael|||0000-0003-1675-3173
  • González-López, Juanjo|||0000-0003-2419-5909
  • Martínez-Martínez, Luis
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
  • Oliver, Antonio|||0000-0001-9327-1894
  • Palacios-Baena, Zaira R.|||0000-0002-1713-6807
  • Pascual Hernández, Álvaro|||0000-0002-8672-5891
  • Ruiz-Carrascoso, Guillermo
  • Vila Estapé, Jordi|||0000-0002-8025-3926
  • Aracil, Belén
  • Pérez-Vázquez, María
  • Oteo-Iglesias, Jesús|||0000-0003-3327-8263
Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effects of the COVID-19 Pandemic on Incidence and Epidemiology of Catheter-Related Bacteremia, Spain

  • Gasch, Oriol|||0000-0001-8518-458X
  • Badia Cebada, Laia|||0000-0002-9321-8492
  • Carmezim, João
  • Vaqué, Montserrat
  • Pomar, Virginia|||0000-0002-8473-5834
  • Moreno, Encarna
  • Marrón, Anna
  • Jiménez Martínez, Emili
  • García Quesada, María José|||0000-0002-0206-7597
  • Garcia Alarcón, Xavier
  • Domènech, Dolors
  • Càmara, Jordi|||0000-0002-0817-0931
  • Andrés Nieto, Marta|||0000-0001-5267-0039
  • Peñafiel, Judith|||0009-0006-6688-6395
  • Porrón, Rosario
  • Limón, Enric|||0000-0002-5396-1521
  • Calbo Sebastián, Esther|||0000-0001-7750-5347
  • Pujol, Miquel|||0000-0002-6475-6208
We compared hospital-acquired catheter-related bacteremia (CRB) episodes diagnosed at acute care hospitals in Catalonia, Spain, during the COVID-19 pandemic in 2020 with those detected during 2007-2019. We compared the annual observed and predicted CRB rates by using the negative binomial regression model and calculated stratified annual root mean squared errors. A total of 10,030 episodes were diagnosed during 2007-2020. During 2020, the observed CRB incidence rate was 0.29/10 patient-days, whereas the predicted CRB rate was 0.14/10 patient-days. The root mean squared error was 0.153. Thus, a substantial increase in hospital-acquired CRB cases was observed during the COVID-19 pandemic in 2020 compared with the rate predicted from 2007-2019. The incidence rate was expected to increase by 1.07 (95% CI 1-1.15) for every 1,000 COVID-19-related hospital admissions. We recommend maintaining all CRB prevention efforts regardless of the coexistence of other challenges, such as the COVID-19 pandemic.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A New Integrative and Mobilizable Element Is a Major Contributor to Tetracycline Resistance in Streptococcus dysgalactiae subsp. equisimilis

  • López de Egea, Guillem|||0000-0002-4196-7627
  • Gonzalez Diaz, Aida|||0000-0002-8326-1307
  • Guédon, Gérard|||0000-0002-5289-3803
  • Lao, Julie
  • Berbel, Dàmaris|||0000-0002-3689-3360
  • Casabella Pernas, Antonio|||0000-0002-2534-3689
  • Marimón, José María|||0000-0002-2787-7094
  • Cercenado, Emilia|||0000-0002-5279-3773
  • Fernández-Delgado, Lucía|||0000-0001-8815-0967
  • Chiapello, Hélène
  • Lacroix, Thomas|||0000-0002-6708-5809
  • Domínguez, María Ángeles
  • Leblond-Bourget, Nathalie|||0000-0001-5739-1370
  • Ardanuy, Carmen|||0000-0003-0225-607X
Tetracycline resistance in streptococci is mainly due to ribosomal protection mediated by the tet (M) gene that is usually located in the integrative and conjugative elements (ICEs) of the Tn 916 -family. In this study, we analyzed the genes involved in tetracycline resistance and the associated mobile genetic elements (MGEs) in Streptococcus dysgalactiae subsp. equisimilis (SDSE) causing invasive disease. SDSE resistant to tetracycline collected from 2012 to 2019 in a single hospital and from 2018 in three other hospitals were analyzed by whole genome sequencing. Out of a total of 84 SDSE isolates, 24 (28.5%) were resistant to tetracycline due to the presence of tet (M) (n = 22), tet (W) (n = 1), or tet (L) plus tet (W) (n = 1). The tet (M) genes were found in the ICEs of the Tn 916 -family (n = 10) and in a new integrative and mobilizable element (IME; n = 12). Phylogenetic analysis showed a higher genetic diversity among the strains carrying Tn 916 than those having the new IME, which were closely related, and all belonged to CC15. In conclusion, tetracycline resistance in SDSE is mostly due to the tet (M) gene associated with ICEs belonging to the Tn 916 -family and a new IME. This new IME is a major cause of tetracycline resistance in invasive Streptococcus dysgalactiae subsp. equisimilis in our settings.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation

  • Masip, Jenifer|||0000-0002-9233-5195
  • Jorba, Rosa|||0000-0003-3307-4340
  • López Dupla, Jesús Miguel|||0000-0002-9141-2523
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Pacheco, Yolanda M.|||0000-0002-9451-8083
  • García-Pardo, Graciano|||0000-0003-0274-6001
  • Martínez, Esteban|||0000-0002-6911-8846
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Veloso Esteban, Sergio|||0000-0001-7943-1169
  • Alba, Verónica|||0000-0002-5925-9573
  • Olona, Montserrat|||0000-0001-5303-9361
  • Vidal, Francesc|||0000-0002-6692-6186
  • Gómez-Bertomeu, Frederic
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Rull, Anna|||0000-0002-8907-7754
Nuclear magnetic resonance (NMR)-based advanced lipoprotein tests have demonstrated that LDL and HDL particle numbers (LDL-P and HDL-P) are more powerful cardiovascular (CV) risk biomarkers than conventional cholesterol markers. Of interest, in people living with HIV (PLHIV), predictors of preclinical atherosclerosis and vascular dysfunction may be associated with impaired immune function. We previously stated that immunological non-responders (INR) were at higher CV risk than immunological responders (IR) before starting antiretroviral therapy (ART). Using Liposcale tests, we characterized the lipoprotein profile from the same cohort of PLHIV at month 12 and month 36 after starting ART, intending to explore what happened with these indicators of CV risk during viral suppression. ART initiation dissipates the differences in lipoprotein-based CV risk markers between INR and IR, and only an increase in the number of HDL-P was found in INR + IR when compared to controls (p = 0.047). Interestingly, CD4 T-cell counts negatively correlated with medium HDL-P concentrations at month 12 in all individuals (ρ = -0.335, p = 0.003). Longitudinal analyses showed an important increase in LDL-P and HDL-P at month 36 when compared to baseline values in both IR and INR. A proper balance between a proatherogenic and atherogenic environment may be related to the reconstitution of CD4 T-cell count in PLHIV.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epidemiological survey and risk factors associated with Paslahepevirus balayani in equines in Europe

  • Caballero-Gómez, Javier|||0000-0002-6241-3439
  • Rivero-Juarez, Antonio|||0000-0002-5813-6889
  • Cano-Terriza, David|||0000-0001-5657-2567
  • Fajardo, Tomás
  • Buono, Francesco
  • José Cunilleras, Eduard|||0000-0002-4536-7717
  • García Macías, Jesús
  • Alguacil, Eduardo
  • Rivero Román, Antonio|||0000-0002-8643-4250
  • García Bocanegra, Ignacio|||0000-0003-3388-2604
Paslahepevirus balayani (HEV) is an important emerging zoonotic virus in Europe. Although domestic pigs and wild boar are the main reservoirs of this pathogen, susceptibility to this virus has been confirmed in a growing number of animal species, including equines. However, their role in the epidemiology of this virus remains poorly understood. Our aim was to assess HEV circulation and identify potential risk factors associated with exposure in equid species in different European countries. A total of 596 equines, including 496 horses, 63 donkeys and 37 mules/hinnies bred in four European countries (Spain, Italy, United Kingdom and Ireland) were sampled. Thirty-three animals (5.5%; 95%CI: 3.7-7.4) had anti-HEV antibodies. Seropositivity was found in 4.6% of horses, 11.1% of donkeys and 8.1% of mules/hinnies tested. By country, 6.3%, 5.4%, 5.0% and 4.0% of the equines sampled in Spain, Italy, United Kingdom and Ireland, respectively, were seropositive, respectively. Statistical analysis showed that "species" and "drinking water from ponds and streams" were potential risk factors associated with HEV seropositivity in equines in Europe. HEV RNA was not detected in any (0.0%; 95%CI: 0.0-1.8) of the 202 equines tested. Our results provide evidence of a low, spatially homogeneous and widespread viral circulation that is not equal across species in equid populations in the European countries analyzed and indicate that these species appear to play a limited role in the epidemiology of this virus. Further studies are required to elucidate the differences in seroprevalence between donkeys, mules/hinnies and horses and to determine the risk of zoonotic transmission of this pathogen from equid species.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy

  • Resa-Infante, Patricia|||0000-0002-1727-592X
  • Erkizia, Itziar|||0000-0003-1244-8972
  • Muñiz-Trabudua, Xabier|||0000-0002-1142-4381
  • Linty, Federica
  • Bentlage, Arthur E.H.
  • Perez-Zsolt, Daniel|||0000-0003-4192-7622
  • Muñoz-Basagoiti, Jordana|||0000-0002-0384-5928
  • Raïch-Regué, Dàlia|||0000-0001-7656-5700
  • Izquierdo Useros, Nuria|||0000-0002-1039-1821
  • Rispens, Theo
  • Vidarsson, Gestur
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
New therapies to treat or prevent viral infections are essential, as recently observed during the COVID-19 pandemic. Here, we propose a therapeutic strategy based on monoclonal antibodies that block the specific interaction between the host receptor Siglec-1/CD169 and gangliosides embedded in the viral envelope. Antibodies are an excellent option for treating infectious diseases based on their high specificity, strong targeting affinity, and relatively low toxicity. Through a process of humanization, we optimized monoclonal antibodies to eliminate sequence liabilities and performed biophysical characterization. We demonstrated that they maintain their ability to block viral entry into myeloid cells. These molecular improvements during the discovery stage are key if we are to maximize efforts to develop new therapeutic strategies. Humanized monoclonal antibodies targeting CD169 provide new opportunities in the treatment of infections caused by ganglioside-containing enveloped viruses, which pose a constant threat to human health. In contrast with current neutralizing antibodies that bind antigens on the infectious particle, our antibodies can prevent several types of enveloped viruses interacting with host cells because they target the host CD169 protein, thus becoming a potential pan-antiviral therapy.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

No innocent bystanders: pertussis vaccination and evolutionary parallelisms between Bordetella parapertussis and Bordetella pertussis

  • Bouchez, Valérie
  • Landier, Annie
  • Armatys, Nathalie
  • Guillot, Sophie
  • Moreno-Mingorance, Albert
  • Mir-Cros, Alba
  • Martin Gomez, M. Teresa
  • González-López, Juan José
Bordetella parapertussis; Phylogenetic diversity; Vaccine driven evolution, Bordetella parapertussis; Diversidad filogenética; Evolución impulsada por vacunas, Bordetella parapertussis; Diversitat filogenètica; Evolució impulsada per vacunes, Pathogens adapting to the human host and to vaccination-induced immunity may follow parallel evolutionary paths. Bordetella parapertussis (Bpp) contributes significantly to the burden of whooping cough (pertussis) and shares vaccine antigens with Bordetella pertussis (Bp); both pathogens are phylogenetically related and ecological competitors. Bp vaccine antigen-coding genes have accumulated variation, including pertactin (PRN) disruptions, after the introduction of acellular vaccines in the 1990s. We aimed to evaluate evolutionary parallelisms in Bpp, even though pertussis vaccines were designed against Bp. We sequenced 242 Bpp isolates collected in France, the USA and Spain between 1937 and 2019, spanning pre-vaccine and two vaccines eras. We investigated the temporal evolution of Bpp sublineages using a Bayesian approach based on whole-genome SNPs and performed comparative genomic analyses focusing on antigen and virulence gene loci. The most recent common ancestor of all sequenced Bpp isolates was estimated around the year 1877, making it one of the youngest human pathogens, and the Bpp evolutionary rate we estimated (2.12×10−7 substitutions per site per year) was remarkably similar to the one previously reported for Bp (2.24×10−7). PRN antigen deficiency in Bpp was driven by 18 disruptive mutations, including deletion prn:ΔG-1895 estimated to have occurred around 1998 and observed in 73.8 % (149/202) of post-2007 Bpp isolates. In addition, we detected two early (year ~1900) mutations in the bvgA-fhaB intergenic region, which controls multiple virulence factors including the filamentous haemagglutinin antigen. Gene clusters for pertussis toxin and fimbriae showed a surprising lack of gene decay. Our findings suggest early adaptation of Bpp to humans through modulation of the bvgAS regulon, and a rapid adaptation through the loss of PRN expression, representing a late evolutionary parallelism concomitant with acellular vaccination against whooping cough., The French National Reference Center for Whooping Cough and Other Bordetella Infections receives support from Institut Pasteur and Public Health France (Santé publique France, Saint Maurice, France). This work was supported financially by the French Government’s Investissement d’Avenir grants Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID) and INCEPTION (ANR-16-CONV-0005) and by the Spanish ‘Ministerio de Economía y Competitividad’ and ‘Instituto de Salud Carlos III’ [grant number FIS PI18/00703], and by the Centro de Investigación Biomédica en Red (CIBER de Enfermedades Infecciosas [grant number CB21/13/00054]). This work was also supported by the CDC’s Advanced Molecular Detection (AMD) programme.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Prevalence and morbidity of urogenital schistosomiasis among pre-school age children in Cubal, Angola

  • Sánchez-Marqués, Raquel
  • Bocanegra García, Maria Cristina
  • Nindia, Arlette
  • Pintar, Zeferino
  • Aixut, Sandra
  • Martínez-Campreciós, Joan
  • Sulleiro, Elena
  • Espiau, María
  • Molina Romero, Israel
  • Salvador Velez, Fernando
Morbidity; Urine; Schistosomiasis, Morbilidad; Orina; Esquistosomiasis, Morbilitat; Orina; Esquistosomiasi, Background: Schistosomiasis is one of the most important neglected tropical diseases, with a great impact on public health and more than 200,000 deaths annually. Schistosoma haematobium causes urinary tract (UT) morbidity. Since schistosomiasis morbidity control programs focus on children older than 5 years, pre-school age children (PSAC) morbidity is not well known. Methods: We conducted a cross-sectional study in Cubal (Angola) among 245 PSAC with the objective of evaluating the prevalence of S. haematobium infection, the intensity of infection, and associated morbidity. For this purpose, urine filtration test followed by microscopic visualization and ultrasound examinations were performed. Results: The estimated overall prevalence of urogenital schistosomiasis was 30.2% (CI 95%; 24.5-35.9), with 20.3% (CI 95%; 15.3-25.3) of the samples analysed showing a high intensity of infection. A total of 54.5% (CI 95%; 47.6-61.8) of infected children presented UT lesions, showing a significant association between schistosomiasis infection and UT morbidity (p-value < 0.001). Bladder wall thickening was the most common lesion, being present in 100% of abnormal ultrasounds. We found that anaemia and severe malnutrition were not significantly associated with the development of UT lesions. Conclusions: S. haematobium infection in PSAC causes great UT detectable morbidities. Therefore, there is an evident need of including them in mass drug administration (MDA) campaigns and consequently the development of an adapted praziquantel treatment dosage for children under 2 years of age., This research was supported by the Red de Investigación de Centros de Enfermedades Tropicales–RICET (Grant No. RD16/0027/0023 and RD16/0027/0003) of the PN de I+D+I, ISCIII-Subdirección General de Redes y Centros de Investigación Cooperativa RETICS), Spanish Ministry of Health and Consumption; by CIBER de Enfermedades Infecciosas (Grant No. CB21/13/00056 and CB21/13/00029), ISCIII, Spanish Ministry of Science and Education; and by the PROMETEO Program, Programa of Ayudas para Grupos de Investigación de Excelencia, Generalitat Valenciana (Grant No. 2021/004).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Increasing trend of antimicrobial resistance in Shigella associated with MSM transmission in Barcelona, 2020–21: outbreak of XRD Shigella sonnei and dissemination of ESBL-producing Shigella flexneri

  • Moreno-Mingorance, Albert
  • Mir Cros, Alba
  • Goterris Bonet, Lidia
  • Rodríguez Garrido, Virginia
  • Sulleiro, Elena
  • Barberà Gracia, Mª Jesús
  • Descalzo Jorro, Vicente
  • Bravo, Albert
  • Roca, Josep
  • González-López, Juan José
  • Pumarola Suñe, Tomàs
  • VIÑADO, BELEN
  • Larrosa, María Nieves
  • Hoyos Mallecot, Yannick
Antimicrobial resistance; Shigella sonnei; Sexually transmitted infection, Resistencia antimicrobiana; Shigella sonnei; Infección de transmisión sexual, Resistència antimicrobiana; Shigella sonnei; Infecció de transmissió sexual, Background Several countries have recently reported the detection of ESBL-producing Shigella sonnei associated with transmission among MSM. In a previous study by our group, 2.8% of Shigella spp. obtained from MSM in Barcelona between 2015 and 2019 were ESBL producers. Objectives To describe and characterize the emerging ESBL-producing Shigella spp. associated with sexual transmission among MSM detected from 2020 to 2021 in Barcelona, elucidating their connectivity with contemporaneous ESBL-producing Shigella spp. from other countries. Results From 2020 to 2021, we identified that among MSM, 68% of S. sonnei were XDR harbouring blaCTX-M-27 and 14% of Shigella flexneri were MDR harbouring blaCTX-M-27. WGS analysis showed that the ESBL-producing S. sonnei were part of a monophyletic cluster, which included isolates responsible for the prolonged outbreak occurring in the UK. Our data also reveal the first emergence and clonal dissemination of ESBL-producing and fluoroquinolone-resistant S. flexneri 2a among MSM. Conclusions We report an increasing trend of antimicrobial resistance in Shigella spp. among MSM in Barcelona since 2021, mainly as a consequence of the dissemination of XDR ESBL-producing S. sonnei, previously reported in the UK. These results highlight the importance of international collaborative surveillance of MDR/XDR S. sonnei and S. flexneri for rapid identification of their emergence and the prevention of the transmission of these pathogens., This work was partially supported by the ‘Ministerio de Economía y Competitividad’, ‘Instituto de Salud Carlos III’, and co-financed by the European Regional Development Fund (ERDF) ‘A Way to Achieve Europe’ (Spanish Network for Research in Infectious Diseases, grant number RD16/0016/0003) and by the Centro de Investigación Biomédica en Red (CIBER de Enfermedades Infecciosas, grant no. CB21/13/00054). A.M.M. is supported by a grant from the ‘Fondo de Investigación Sanitaria’ (Contratos Predoctorales de Formación en Investigación, grant number FI19/00315).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Schistosoma haematobium infection and morbidity risk factors for pre-school age children in western Angola: A knowledge, attitudes and practices survey

  • Bocanegra, Cristina
  • Nindia, Arlette
  • Pintar, Zeferino
  • Martínez-Campreciós, Joan
  • Aixut, Sandra
  • Molina Romero, Israel
  • Sánchez-Marqués, Raquel
  • Salvador Velez, Fernando
Schistosomiasis; Medical risk factors; Morbidity, Esquistosomiasi; Factors de risc mèdic; Morbilitat, Esquistosomiasis; Factores de riesgo médico; Morbilidad, Background Urogenital schistosomiasis is one of the most prevalent parasitic diseases in sub-Saharan Africa. It is a poverty-related disease conditioned by behavioural practices. Methods Our objective is to evaluate the awareness, mindset and habits about urogenital schistosomiasis in the community of Cubal (Angola), as well as its association with infection and urinary tract morbidity in pre-school age children. A cross-sectional study of knowledge, attitudes and practices at home was conducted between February and May 2022 with 250 participants. Results Overall, 93.6% of those surveyed had some prior knowledge about schistosomiasis and, among all the symptoms associated with this disease, blood in the urine was the best known (54.4%). Nevertheless, 57.6% obtained a medium knowledge score. Regarding attitude, the majority of respondents had a high attitude score (79.2%) with 96.0% willing to participate in mass drug administration campaigns. Laundry in the river was the most common risk practice (61.2%) and 55.2% out of the total were classified with a low practice score. Conclusion Low knowledge about symptoms and transmission by caregivers was the outstanding risk factor for infection in pre-school age children (OR = 16.93, 95%CI: 3.93–72.82), and lack of knowledge that avoiding entering the river prevents schistosomiasis was the main risk factor for morbidity in PSAC (OR = 8.14, 95%CI: 1.14–58.25)., This research was supported by the Red de Investigación de Centros de Enfermedades Tropicales – RICET of the PN de I+D+I, ISCIII-Subdirección General de Redes y Centros de Investigación Cooperativa RETICS), Ministry of Health and Consumption, Madrid; by CIBER de Enfermedades Infecciosas (Projects CB21/13/00056 and CB21/13/00029), ISCIII, Ministry of Science and Education, Madrid; by Project No. 2021/004 of the PROMETEO Program, Programa de Ayudas para Grupos de Investigación de Excelencia, Generalitat Valenciana, Valencia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

  • Sola-Campoy, Pedro Juan
  • Delgado-Valverde, Mercedes
  • Cano, María E.
  • Gijón, Desirèe
  • Larrosa Escartin, María Nieves
  • Gonzalez Lopez, Juan Jose
  • Cañada-Garcia, Javier E.
  • Moure Garcia, Zaira
Carbapenemases; High-risk clones; Whole genome sequencing, Carbapenemasas; Clones de alto riesgo; Secuenciación del genoma completo, Carbapenemases; Clons d'alt risc; Seqüenciació del genoma sencer, Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were blaOXA–48 (263/377), blaKPC–3 (62/377), blaVIM–1 (28/377), and blaNDM–1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3., This research was supported by grants from the Instituto de Salud Carlos III (numbers PI18CIII/00030 and PI21CIII/00039). It was also supported by Plan Nacional de I + D + i 2013–2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (grants RD16CIII/0004/0002, RD16/0016/0001, RD16/0016/0003, RD16/0016/0004, RD16/0016/0006, RD16/0016/0007, RD16/0016/0008, RD16/0016/0010, and RD16/0016/0011). Cofinanced by the European Development Regional Fund “A way to achieve Europe,” Operative Program Intelligent Growth 2014–2020. CIBER – Consorcio Centro de Investigación Biomédica en Red (CB21/13/00095, CB21/13/00012, CB21/13/00049, CB21/13/00054, CB21/13/00055, CB21/13/00068, CB21/13/00081, CB21/13/00084, and CB21/13/00099) (CIBERINFEC) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU also supported this work.
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Antimicrobial activity of cationic carbosilane dendrimers against clinical strains of extended-spectrum beta-lactamase producing-Escherichia coli and their biofilms

  • Hernando Gozalo, Marcos|||0000-0003-2838-7270
  • Aguilera Correa, John Jairo
  • Ciepluch, Karol
  • Lach, Karolina
  • Rescalvo Casas, Carlos|||0000-0003-3745-6661
  • Seijas Pereda, Laura
  • Cuadros González, Juan|||0000-0003-4098-4377
  • Gómez Ramírez, Rafael|||0000-0001-6448-2414
  • Pérez Tanoira, Ramón|||0000-0002-9816-3208
  • Sánchez-Nieves Fernández, Javier|||0000-0003-0410-2285
12 p., Antimicrobial resistance (AMR) is a significance public health concern with serious health and socioeconomic consequences. Therefore, multidrug-resistant strains such as extended-spectrum beta-lactamase (ESBL) producing-Enterobacterales are becoming increasingly common and there are few antibiotic options to treat them. Consequently, it is urgent to find new therapeutic compounds, and cationic dendrimers, such as carbosilane (CBS) derivatives, with peripheral ammonium groups are possible candidates for this purpose. The aim of this study was to establish the antimicrobial and biological properties of different cationic CBS dendrimers and dendrons against multiresistant clinical strains of ESBL-producing Escherichia coli. All seven compounds tested were found to be effective in vitro against planktonic forms. The most active compounds inhibited the formation of bacterial biofilms but lacked activity against pre-formed biofilms. These dendrimers differed in their mode of action depending on the structure and the cationic groups, which was analysed by studies with interaction of membrane models. In addition, these four dendritic systems mentioned above showed a good therapeutic margin in the haemolysis assays in vitro and they lacked haemagglutinating properties. In conclusion, some of the compounds tested could be candidates as potential topical antimicrobials or disinfectants against ESBL-producing enterobacteria infections., Ministerio de Ciencia e Innovación, Comunidad de Madrid, Universidad de Alcalá, Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Unión Europea, Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias, National Science Centre (Polonia)
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Prevalence and risk factors of active hepatitis C infection among at-risk migrant populations in Madrid, Spain, 2019 to 2023

  • Ryan Murúa, Pablo
  • Valencia la Rosa, Jorge Antonio
  • Pérez García, Felipe|||0000-0002-4885-4334
  • Quero Delgado, Marta
  • Cuevas, Guillermo
  • Manzano, Samuel
  • Estévez, Samuel
  • Martínez, Isidoro
  • Sepúlveda Crespo, Daniel
  • Resino, Salvador
11 p., Background: Hepatitis C virus (HCV) microelimination among at-risk migrants supports global elimination goals. Aim: To evaluate risk factors, prevalence and trends of active HCV infection among at-risk migrants screened for HCV in Madrid from 2019-23. Methods: At-risk migrants (born outside Spain, living in country < 10 years regardless of legal status), were screened for HCV via mobile units with rapid antibody testing, and confirmed by RNA testing. Recruitment of this convenience sample focused on migrant centres, shelters, harm reduction centres and social service sites. Primary outcome was active HCV prevalence. Risk factors analysed included origin, alcohol use, no stable income, drug use and sexual behaviour. Data were analysed using general linear models with negative binomial distribution and p values adjusted for multiple comparisons (q values). Results: Among 2,288 migrants, 6.5% (149/2,288) had anti-HCV antibodies, 47.0% (70/149) of whom tested positive for HCV-RNA; 81.4% (57/70) began antiviral therapy. Overall prevalence of active HCV infection was 3.1% (70/2,288). Injection drug use (non-active vs never used ((aIRR: 7.3; 95% CI:2.7-12.7) and active (aIRR:14.7; 95% CI:6.7-32.1)), European origin (vs non-European; aIRR:5.8; 95% CI: 2.7-12.7) and alcohol misuse (vs no misuse; aIRR: 1.8; 95% CI: 1.1-2.9) were main risk factors. Prevalence showed no significant change during 2019-23 in the overall population and across risk groups. Conclusion: At-risk migrants screened in Madrid had a high prevalence of active HCV infection. This is higher than reported estimates for the general Spanish population and supports the need to enhance targeted HCV prevention, screening and treatment strategies among migrant populations., Gilead Sciences, Instituto de Salud Carlos III, Asociación Española para el Estudio del Hígado, Consorcio Centro de Investigación Biomédica en Red, Ministerio de Ciencia e Innovación, Unión Europea, Madrid Positivo Association
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Dynamic ACE2-functionalized magnetic micromotors for electrochemical protein S detection from SARS-CoV-2: toward diagnosis after virus mutation

  • Rodríguez Castillo, Alberto
  • Postigo, Tamara
  • Pérez García, Felipe|||0000-0002-4885-4334
  • Bermejo Martín, Jesús Francisco
  • Jurado Sánchez, Beatriz|||0000-0002-6584-1949
  • Escarpa Miguel, Jesús Alberto|||0000-0002-7302-0948
13 p., Inspired by the diagnostic potential of micromotor technology, this study presents a novel magnetic micromotor-based electrochemical biosensing approach for the sensitive detection of spike (S) protein in microliter-scale sample volumes. Tubular MoS2/Ni magnetic micromotors are externally modified with gold nanoparticles (AuNPs) to enable the covalent immobilization of angiotensin-converting enzyme 2 (ACE2) as the capture probe, leveraging its intrinsic recognition capability and resilience to viral mutations for future-proof detection. The inner Ni layer provides biocompatible magnetic propulsion while simplifying washing and handling steps. The resulting ACE2/Au/MoS2/Ni micromotors are actively navigated for 20 min to efficiently capture the S protein/anti-S IgG/HRP-labeled secondary antibody immunocomplex. After capture, the micromotors are deposited onto a screen-printed electrode for chronoamperometric detection at ?0.1 V using 3,3?,5,5?-tetramethylbenzidine (TMB) as a redox mediator. Micromotor motion is shown to be crucial, enhancing the amperometric signal by approximately 50% in confined sample microenvironments. This clearly demonstrates the active role of micromotor propulsion in promoting target?receptor interactions and improving analytical performance. The biosensing platform achieves a low limit of detection (53 pg/mL) and high selectivity, with negligible cross-reactivity toward protein N and influenza A HA1. Importantly, validation in nasopharyngeal and plasma samples demonstrates the reliable classification of positive and negative cases, highlighting the suitability of the method for rapid screening applications. Overall, this micromotor-based strategy provides a robust, mutationresilient, and decentralized approach for precision biosensing of respiratory infections, with strong potential for future point-of-care development., Agencia Estatal de Investigación, Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Junta de Comunidades de Castilla-La Mancha, Universidad de Alcalá, Fondo Europeo de Desarrollo Regional, NextGenerationEU/PRTR, Unión Europea
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Challenges in accurate HDV RNA quantification: inter-assay variability and the impact of thermal shock

  • Pérez García, Felipe|||0000-0002-4885-4334
  • Virseda Berdices, Ana
  • Pita Martínez, Carlos
  • Muñoz Monte, Mario
  • Sepúlveda Crespo, Daniel
  • Codina, Helena
  • Alonso, Roberto
  • Mesones, Lara
  • Rodrigo, Sandra
  • Macías, Juan Antonio
  • Real, Luis Miguel
  • Cuadros González, Juan|||0000-0003-4098-4377
  • Martínez, Isidoro
  • Resino, Salvador
11 p., Quantitative RT-PCR (qRT-PCR) is essential for monitoring hepatitis delta virus (HDV) RNA, yet assays lack standardization. We aimed to evaluate the performance of three qRT-PCR assays and to assess the impact of a pre-analytical thermal shock procedure. We conducted a comparative study using 206 samples (106 with anti-HDV antibodies and 100 anti-HDV-negative as a control group), which were tested in parallel with three qRT-PCR assays: Vircell, Certest, and Altona. Performance was evaluated for inter-assay agreement (kappa index), quantitative correlation (R²), and bias (BlandAltman). Altona detected 56 HDV-RNA positive samples, whereas Vircell and Certest detected 55 positive samples. Inter-assay agreement was perfect comparing Vircell vs Certest (agreement = 100%, к = 1.000) and almost perfect comparing Altona with both Vircell and Certest (agreement = 99.5%, к = 0.988). Quantitatively, Vircell and Certest assays showed relevant systematic biases compared to Altona, overestimating viral loads by approximately 0.24 log10 International Units (IU)/mL (Certest) and 0.33 log10 IU/mL (Vircell). The correlation with Altona was strong for Certest (R² = 0.864) and moderate for Vircell (R² = 0.793), while the correlation between Certest and Vircell was weaker (R² = 0.720). Thermal shock improved sensitivity in one case (Certest vs Vircell) but increased quantitative variability, worsening the inter-assay correlation (R² = 0.684). In conclusion, all three assays were highly concordant for the qualitative diagnosis of HDV infection, but their quantitative biases prevent their interchangeable use for treatment monitoring. Thermal shock is not recommended for routine monitoring, as a significant compromise in quantitative accuracy and precision outweighs any potential gains in sensitivity., European Society of Clinical Microbiology and Infectious Diseases, Instituto de Salud Carlos III, Centro de Investigación en Red en Enfermedades Infecciosas, Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Prevalence and patterns of antiretroviral resistance in HIV infected Latin American asylum seekers

  • Manzano, Samuel
  • Torres Macho, Juan
  • Deihim Rahampour, Neda
  • Cuevas, Guillermo
  • Pérez García, Felipe|||0000-0002-4885-4334
  • Balsalobre, Luz
  • Resino, Salvador
  • Sánchez Conde, Matilde
  • Valencia la Rosa, Jorge Antonio
  • Ryan Murúa, Pablo
11 p., The recent increase in Latin American asylum seekers in Spain has been accompanied by a rise in HIV diagnoses. However, their clinical profile, particularly regarding antiretroviral resistance, is poorly characterized. We aimed to assess the prevalence of resistance-associated mutations and their impact on treatment management in this vulnerable population. We conducted a prospective cohort study (2022-2023) with six-month follow-up, enrolling Latin American asylum seekers living with HIV, attending their first HIV consultation in Spain. Individuals with a viral load > 1,000 copies/mL, regardless of prior ART exposure, underwent genotypic resistance testing. Mutations were identified using the WHO Surveillance Drug Resistance Mutations (SDRM) list, and resistance was interpreted via the Stanford HIV Drug Resistance Database algorithm. Of 653 participants, 153 met inclusion criteria, and 141 (21.6%) had valid resistance results. Overall, 22.7% harbored SDRMs to NNRTIs, NRTIs, or PIs (15.0% ART-na & iuml;ve vs. 32.8% ART-experienced). NNRTI mutations were most frequent (21.3%), particularly in ART-experienced individuals (31.1%). NRTI mutations were present in 7.1% overall (13.1% ART-experienced). The most common mutations were K103N/S (19.1%), P225H (5.0%), and M184V (4.3%). Among ART-experienced individuals, resistance to efavirenz, nevirapine, and rilpivirine was 31.1%, 32.7%, and 19.7%, respectively; 11.4% showed lamivudine resistance. Notably, 82.3% of ART-experienced participants reported barriers to healthcare access, with a 90% rate of treatment discontinuation. In this cohort of Latin American asylum seekers, resistance to NNRTIs was alarmingly high, especially among those with prior ART exposure and interrupted treatment. These findings underscore the need for optimized treatment strategies and improved healthcare access for migrant populations with HIV., Instituto de Salud Carlos III, Gilead Sciences